https://curecurrent.com/trials/androgen-deprivation-therapy-combined-with-docetaxel-for-high-risk-prostate-cancer-58001https://curecurrent.com/trials/hypofractionated-radiotherapy-for-prostate-cancer-58002https://curecurrent.com/trials/a-study-to-determine-enzalutamide-long-term-safety-and-efficacy-after-anti-androgen-therapy-for-crpc-58003https://curecurrent.com/trials/evaluating-the-impact-of-prostate-only-versus-pelvic-radiation-for-n-prostate-cancer-58004https://curecurrent.com/trials/early-salvage-stereotactic-radiotherapy-for-biochemical-failure-after-rp-58005https://curecurrent.com/trials/validity-reliability-and-minimum-detectable-changes-of-2-minute-walk-timed-up-and-go-sit-and-stand-test-in-patients-with-58006https://curecurrent.com/trials/longitudinal-assessment-of-health-related-quality-of-life-in-men-with-localized-prostate-cancer-58007https://curecurrent.com/trials/exercise-prescription-dose-for-castration-resistance-prostate-cancer-patients-58008https://curecurrent.com/trials/hypofractionated-radiotherapy-as-primary-therapy-for-prostate-cancer-58009https://curecurrent.com/trials/treatment-of-aggressive-prostate-cancer-in-real-life-initiation-schedule-and-management-of-triptorelin-treatment-58010https://curecurrent.com/trials/characterize-tumor-hypoxia-by-magnetic-resonance-imaging-58011https://curecurrent.com/trials/effect-of-peritoneal-fixation-on-lymphocele-formation-58012https://curecurrent.com/trials/a-study-of-neoadjuvant-hormone-therapy-in-patient-with-advanced-prostate-cancer-undergoing-radical-prostatectomy-58013https://curecurrent.com/trials/effect-of-beta-alanine-and-pelvic-floor-muscle-training-on-urinary-incontinence-after-radical-prostatectomy-bela-58014https://curecurrent.com/trials/neoadjuvant-therapy-of-abiraterone-plus-adt-for-high-risk-prostate-cancer-58015https://curecurrent.com/trials/fasting-and-nutritional-therapy-in-patients-with-advanced-metastatic-prostate-cancer-58016https://curecurrent.com/trials/hypofractionated-stereotactic-body-radiation-therapy-for-patients-with-prostate-cancer-that-was-removed-by-surgery-58017https://curecurrent.com/trials/prostate-pmsabr-study-58018https://curecurrent.com/trials/multidisciplinary-care-after-prostatectomy-58019https://curecurrent.com/trials/prospective-registry-of-targeted-radionuclide-therapy-in-patients-with-mcrpc-reality-study-58020https://curecurrent.com/trials/postoperative-patient-comfort-and-quality-of-micturition-in-suprapubic-tube-vs-transurethral-catheterization-after-rarp-58021https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-prostate-cancer-58022https://curecurrent.com/trials/intestinal-microbiota-in-prostate-cancer-patients-as-a-biomarker-for-radiation-induced-toxicity-imprint-58023https://curecurrent.com/trials/68ga-labeled-ny108-pet-imaging-in-patients-58024https://curecurrent.com/trials/transurethral-prostate-enucleation-in-surveillance-protocol-for-low-risk-prostate-cancer-58025https://curecurrent.com/trials/stereotactic-body-radiation-for-prostate-oligometastases-58026https://curecurrent.com/trials/68ga-p15-041-and-68ga-psma-11-pet-ct-imaging-in-the-same-group-of-prostate-bone-metastasis-58027https://curecurrent.com/trials/radiotherapy-adjuvant-versus-early-salvage-58028https://curecurrent.com/trials/docetaxel-and-carboplatin-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-containing-inactivat-58029https://curecurrent.com/trials/study-of-safety-pharmacokinetic-and-efficacy-of-apg-5918-in-advanced-solid-tumors-or-lymphomas-58030https://curecurrent.com/trials/prostate-reirradiation-toxicity-outcomes-feasibility-study-58031https://curecurrent.com/trials/prostate-testing-for-cancer-and-treatment-58032https://curecurrent.com/trials/prostvac-in-patients-with-biochemically-recurrent-prostate-cancer-58033https://curecurrent.com/trials/a-study-on-drug-drug-interactions-in-patients-treated-with-anticancer-agents-for-a-prostate-cancer-in-real-life-setting-58034https://curecurrent.com/trials/bone-marrow-suppression-and-recovery-during-radionuclide-treatment-58035https://curecurrent.com/trials/the-improving-cancer-aftercare-study-58036https://curecurrent.com/trials/addition-of-a-focal-boost-in-external-beam-radiotherapy-for-locally-advanced-prostate-cancer-by-online-adaptive-mr-guide-58037https://curecurrent.com/trials/posterior-urethrovesical-anastomotic-reconstruction-in-comparison-to-conventional-urethrovesical-anastomosis-58038https://curecurrent.com/trials/olaparib-maintenance-in-patients-with-mcrpc-after-docetaxel-treatment-reaching-partial-or-stable-response-imanol-58039https://curecurrent.com/trials/prostate-cancer-screening-with-abbreviated-mri-protocol-58040https://curecurrent.com/trials/hemi-ablative-prostate-brachytherapy-58041https://curecurrent.com/trials/evaluation-of-the-safety-of-intraperitoneal-laparoscopic-radical-prostatectomy-with-or-without-drainage-tube-58042https://curecurrent.com/trials/biparametric-mri-in-prostate-cancer-screening-a-noninferior-randomized-controlled-study-58043https://curecurrent.com/trials/using-rectal-hydrogel-spacer-for-salvage-sabr-in-prostate-cancer-58044https://curecurrent.com/trials/anesthesia-in-prostate-biopsy-pain-obstruction-study-58045https://curecurrent.com/trials/determining-the-clinical-relevance-of-the-interaction-between-enzalutamide-and-the-opioid-morphine-and-the-doac-edoxaban-58046https://curecurrent.com/trials/radio-guided-surgery-with-drop-in-beta-probe-for-68ga-psma-in-high-risk-prostate-cancer-patients-eligible-for-robotic-as-58047https://curecurrent.com/trials/mri-guided-focal-laser-ablation-prostate-cancer-58048https://curecurrent.com/trials/a-trial-of-immunotherapy-strategies-in-metastatic-hormone-sensitive-prostate-cancer-58049https://curecurrent.com/trials/comparison-of-a-novel-transperineal-targeted-fusion-biopsy-system-to-conventional-transrectal-targeted-fusion-biopsy-58050https://curecurrent.com/trials/the-study-of-olaparib-combined-with-abiraterone-and-prednisone-in-mhspc-patients-with-hrr-gene-mutation-58051https://curecurrent.com/trials/the-efficacy-and-safety-of-docetaxel-combined-with-platinum-for-metastatic-hormone-sensitive-prostate-cancer-58052https://curecurrent.com/trials/study-of-enzalutamide-in-patients-with-castration-resistant-prostate-cancer-58053https://curecurrent.com/trials/a-prospective-study-of-free-hand-transperineal-image-fusion-targeted-biopsies-under-local-anesthesia-58054https://curecurrent.com/trials/prospective-comparison-of-the-four-biopsy-methods-for-prostate-cancer-detection-58055https://curecurrent.com/trials/cystoprostatectomy-versus-radiotherapy-combined-with-adt-for-the-treatment-of-ct4-prostate-cancer-with-bladder-invasion-58056https://curecurrent.com/trials/68ga-psma-11-pet-ct-for-the-diagnosis-of-bone-metastases-in-patients-with-prostate-cancer-and-biochemical-progression-du-58057https://curecurrent.com/trials/impact-of-atorvastatin-on-prostate-cancer-progression-during-adt-58058https://curecurrent.com/trials/177lu-ludotadipep-treatment-in-patients-with-metastatic-castration-resistant-prostate-cancer-58059https://curecurrent.com/trials/liquid-biopsy-based-detection-of-resistance-to-targeted-therapy-in-prostate-cancer-patients-58060https://curecurrent.com/trials/intimacy-enhancing-couples-intervention-for-localized-prostate-cancer-58061https://curecurrent.com/trials/tumor-molecular-profiling-in-patients-with-prostate-cancer-58062https://curecurrent.com/trials/feasibility-and-safety-of-physical-exercise-in-men-with-prostate-cancer-58063https://curecurrent.com/trials/stereotactic-boost-and-long-term-androgen-deprivation-for-adenocarcinoma-of-the-prostate-58064https://curecurrent.com/trials/the-application-research-of-ultrasound-guided-puncture-stent-assisted-transperineal-prostate-biopsy-58065https://curecurrent.com/trials/metformin-prostate-cancer-adjuvant-trial-58066https://curecurrent.com/trials/68ga-psma-pet-in-diagnosing-metastasis-in-patients-with-ovarian-cancer-58067https://curecurrent.com/trials/improving-urinary-continence-and-quality-of-life-in-prostate-cancer-patients-58068https://curecurrent.com/trials/a-pilot-study-of-vaccination-with-epitope-enhanced-tarp-peptide-and-tarp-peptide-pulsed-dendritic-cells-in-the-treatment-58069https://curecurrent.com/trials/a-research-for-combination-of-prostate-health-index-phi-and-mpmri-pi-rads-in-the-diagnosis-of-prostate-cancer-58070https://curecurrent.com/trials/testing-the-effect-of-mindfulness-for-prostatectomy-outcomes-58071https://curecurrent.com/trials/abiraterone-radiotherapy-and-short-term-androgen-deprivation-in-unfavorable-localized-prostate-cancer-58072https://curecurrent.com/trials/impact-of-abdominal-incompetence-on-urinary-incontinence-after-prostatectomy-prostabdo-58073https://curecurrent.com/trials/a-study-comparing-arb-with-radium-223-vs-arb-therapy-with-placebo-and-the-effect-upon-survival-for-mcrpc-patients-58074https://curecurrent.com/trials/combidex-uspio-ultra-small-superparamagnetic-iron-oxide-58075https://curecurrent.com/trials/exodx-prostate-evaluation-in-active-surveillance-patient-population-58076https://curecurrent.com/trials/detection-of-arv7-in-the-plasma-of-men-with-advanced-metastatic-castrate-resistant-prostate-cancer-mcrp-58077https://curecurrent.com/trials/enzalutamide-and-decitabine-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-58078https://curecurrent.com/trials/the-effects-of-method-of-anaesthesia-on-the-safety-and-effectiveness-of-radical-retropubic-prostatectomy-58079https://curecurrent.com/trials/temsirolimus-and-vorinostat-in-treating-patients-with-metastatic-prostate-cancer-58080https://curecurrent.com/trials/hypofractionated-radiotherapy-in-prostate-cancer-patients-aged-75-years-or-older-58081https://curecurrent.com/trials/a-behavioral-health-intervention-using-digital-technology-in-radiation-therapy-for-prostate-cancer-patients-58082https://curecurrent.com/trials/trial-of-hypofractionated-imrt-boost-versus-conventional-imrt-boost-for-localized-high-risk-prostate-cancer-58083https://curecurrent.com/trials/a-biomarker-study-of-standard-of-care-radium-223-chloride-for-metastatic-castration-resistant-prostate-cancer-58084https://curecurrent.com/trials/sbrt-stad-for-unfavorable-intermediate-risk-high-risk-prostate-cancer-58085https://curecurrent.com/trials/nivolumab-and-ipilimumab-treatment-in-prostate-cancer-with-an-immunogenic-signature-58086https://curecurrent.com/trials/5-fractions-of-pelvic-sabr-with-intra-prostatic-sabr-boost-58087https://curecurrent.com/trials/genistein-supplementation-to-mitigate-cardiometabolic-dysfunction-in-patients-undergoing-androgen-deprivation-therapy-fo-58088https://curecurrent.com/trials/vaccine-therapy-in-curative-resected-prostate-cancer-patients-58089https://curecurrent.com/trials/cost-talk-discussing-cancer-care-costs-58090https://curecurrent.com/trials/impact-of-acetazolamide-in-reducing-referred-postoperative-pain-58091https://curecurrent.com/trials/evaluation-of-psma-antagonist-produced-by-two-different-methods-58092https://curecurrent.com/trials/18f-facbc-pet-ct-and-the-psa-kinetics-for-pca-patients-with-biochemical-recurrence-58093https://curecurrent.com/trials/effect-of-androgen-receptor-signaling-inhibitors-on-68ga-psma-11-pet-ct-imaging-in-patients-with-castration-resistant-pr-58094https://curecurrent.com/trials/neoadjuvant-androgen-deprivation-therapy-plus-abiraterone-with-or-without-apalutamide-for-high-risk-prostate-cancer-58095https://curecurrent.com/trials/radiotherapy-for-oligometastatic-prostate-cancer-58096https://curecurrent.com/trials/baseline-testosterone-as-a-prognostic-and-or-predictive-biomarker-in-mhspc-58097https://curecurrent.com/trials/neoadjuvant-hiltonol-polyiclc-for-prostate-cancer-58098https://curecurrent.com/trials/expression-of-steap-1-and-p40-in-prostatic-carcinoma-and-its-mimickers-58099https://curecurrent.com/trials/investigation-of-tumor-microenvironment-after-crpc-along-with-before-and-after-neoadjuvant-therapy-for-prostate-cancer-58100https://curecurrent.com/trials/lee011-ribociclib-in-combination-with-docetaxel-plus-prednisone-in-mcrpc-58101https://curecurrent.com/trials/prospective-evaluation-of-focal-brachytherapy-using-cesium-131-for-patients-with-low-risk-prostate-cancer-58102https://curecurrent.com/trials/sbrt-for-oligometastatic-castration-refractory-prostate-cancer-58103https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-transperineal-irreversible-electroporation-ire-of-anterior-prostate-cancer-58104https://curecurrent.com/trials/the-role-of-the-seven-sweeps-in-the-prevention-of-the-prostate-cancer-among-those-with-a-positive-family-history-58105https://curecurrent.com/trials/neoadjuvant-intense-endocrine-therapy-for-high-risk-and-locally-advanced-prostate-cancer-58106https://curecurrent.com/trials/champ-a-randomized-controlled-trial-of-high-intensity-aerobic-and-resistance-exercise-for-metastatic-prostate-cancer-58107https://curecurrent.com/trials/identify-genes-pathways-responsible-for-progression-from-low-risk-to-higher-risk-prostate-cancer-58108https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-for-oligometastatic-prostate-cancer-58109https://curecurrent.com/trials/low-dose-hemi-body-radiation-for-recurrent-prostate-cancer-58110https://curecurrent.com/trials/trial-comparing-radical-radiotherapy-to-prostate-only-vs-prostate-and-pelvic-lymph-nodes-in-intermediate-and-high-risk-p-58111https://curecurrent.com/trials/apalutamide-and-gonadotropin-releasing-hormone-analog-with-or-without-abiraterone-acetate-in-treating-participants-with-58112https://curecurrent.com/trials/dose-escalation-and-dose-expansion-study-of-gsk525762-in-combination-with-androgen-deprivation-therapy-in-participants-w-58113https://curecurrent.com/trials/evaluation-of-diet-and-exercise-in-prostate-cancer-patients-58114https://curecurrent.com/trials/68ga-p16-093-and-68ga-psma-617-pet-ct-imaging-in-the-same-group-of-prostate-cancer-patients-58115https://curecurrent.com/trials/study-of-nuv-422-in-combination-with-enzalutamide-in-patients-with-mcrpc-58116https://curecurrent.com/trials/neoantigen-dna-vaccine-in-combination-with-nivolumab-ipilimumab-and-prostvac-in-metastatic-hormone-sensitive-prostate-ca-58117https://curecurrent.com/trials/cognitive-behavioral-stress-management-cbsm-prostate-cancer-58118https://curecurrent.com/trials/an-electronic-registry-to-improve-adherence-to-active-surveillance-monitoring-at-a-safety-net-hospital-58119https://curecurrent.com/trials/a-study-of-definitive-therapy-to-treat-prostate-cancer-58120https://curecurrent.com/trials/early-salvage-therapy-for-patients-with-advanced-features-for-biochemical-relapse-after-radical-prostatectomy-for-locali-58121https://curecurrent.com/trials/biomarker-analysis-of-castration-resistant-prostate-cancer-undergoing-bipolar-androgen-therapy-58122https://curecurrent.com/trials/evaluation-of-knowledge-and-practice-about-prostate-cancer-in-male-employees-58123https://curecurrent.com/trials/study-of-anti-psma-car-nk-cell-tabp-eic-in-metastatic-castration-resistant-prostate-cancer-58124https://curecurrent.com/trials/pinpoint-feasibility-study-58125https://curecurrent.com/trials/carinae-for-stress-relief-in-perioperative-care-58126https://curecurrent.com/trials/novel-mri-assessment-of-prostate-cancer-validate-pro-58127https://curecurrent.com/trials/pre-operative-single-shot-rectus-sheath-block-58128https://curecurrent.com/trials/staple-vs-suture-in-robotic-prostatectomy-58129https://curecurrent.com/trials/ablation-of-prostate-tissue-utilizing-sterile-water-vapor-in-patients-with-intermediate-risk-localized-prostate-cancer-58130https://curecurrent.com/trials/informed-decision-making-intervention-in-screening-for-prostate-cancer-of-predominantly-african-american-participants-in-58131https://curecurrent.com/trials/cancer-localization-in-the-prostate-with-f-18-fluorocholine-positron-emission-tomography-58132https://curecurrent.com/trials/predictive-factors-for-tolerance-to-taxane-based-chemotherapy-in-older-adults-affected-by-metastatic-prostate-cancer-58133https://curecurrent.com/trials/initiative-to-minimize-disparities-in-postoperative-prostate-cancer-care-58134https://curecurrent.com/trials/therapeutic-efficiency-and-response-to-2-0-gbq-55mci-177lu-eb-psma-in-patients-with-mcrpc-58135https://curecurrent.com/trials/stereotactic-salvage-radiotherapy-for-macroscopic-prostate-bed-recurrence-after-prostatectomy-a-prospective-observationa-58136https://curecurrent.com/trials/a-multi-centre-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-capivasertib-azd5363-in-combination-with-58137https://curecurrent.com/trials/enzalutamide-and-mifepristone-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-58138https://curecurrent.com/trials/combining-crlx101-a-nanoparticle-camptothecin-with-enzalutamide-in-people-with-progressive-metastatic-castration-resista-58139https://curecurrent.com/trials/daily-long-term-intermittent-fasting-for-the-prevention-of-psa-recurrence-in-patients-with-localized-prostate-cancer-aft-58140https://curecurrent.com/trials/androgen-deprivation-therapy-radium-223-dichloride-in-metastatic-prostate-cancer-with-bone-metastases-58141https://curecurrent.com/trials/ogx-427-in-metastatic-castrate-resistant-prostate-cancer-with-prostate-specific-antigen-progression-while-receiving-abir-58142https://curecurrent.com/trials/assess-the-safety-tolerability-pk-and-anti-tumor-efficacy-of-dzd2269-in-patients-with-mcrpc-58143https://curecurrent.com/trials/a-head-to-head-comparative-study-of-18f-psma-1007-pet-ct-and-18f-fdg-pet-ct-imaging-in-multiple-myeloma-58144https://curecurrent.com/trials/proclaim-germline-genetic-testing-for-prostate-cancer-patients-58145https://curecurrent.com/trials/a-study-of-abiraterone-in-combination-with-shr3162-in-the-treatment-of-mcrpc-58146https://curecurrent.com/trials/bibw-2992-afatinib-for-the-treatment-of-patients-with-her2-positive-hormone-refractory-prostate-cancer-58147https://curecurrent.com/trials/pilot-study-evaluating-the-role-of-histopathology-correlation-in-treatment-planning-58148https://curecurrent.com/trials/a-trial-comparing-cardiovascular-safety-of-degarelix-versus-leuprolide-in-patients-with-advanced-prostate-cancer-and-car-58149https://curecurrent.com/trials/immediate-prostatectomy-vs-cabozantinib-followed-by-prostatectomy-in-men-with-high-risk-prostate-cancer-58150https://curecurrent.com/trials/comparison-of-multiparametric-prostate-mri-and-ga-68-psma-pet-imaging-in-prostate-cancer-staging-58151https://curecurrent.com/trials/efficacy-and-safety-study-of-darolutamide-odm-201-in-men-with-high-risk-non-metastatic-castration-resistant-prostate-can-58152https://curecurrent.com/trials/hemopatch-to-prevent-lymphatic-leak-after-robotic-prostatectomy-and-pelvic-lymph-node-dissection-58153https://curecurrent.com/trials/re-sensitizing-with-supraphysiologic-testosterone-to-overcome-resistance-the-restore-study-58154https://curecurrent.com/trials/retrospective-evaluation-of-a-commercially-available-hydrogel-spacer-bp-009-58155https://curecurrent.com/trials/a-phase-ii-clinical-study-of-stereotactic-radiation-therapy-in-patients-with-high-risk-prostate-cancer-58156https://curecurrent.com/trials/men-undergoing-radical-prostatectomy-58157https://curecurrent.com/trials/study-to-gather-information-about-the-use-of-healthcare-services-and-the-way-the-disease-is-cared-for-in-canadian-patien-58158https://curecurrent.com/trials/fecal-microbiota-transplant-and-pembrolizumab-for-men-with-metastatic-castration-resistant-prostate-cancer-58159https://curecurrent.com/trials/long-term-study-to-evaluate-and-clinical-outcomes-in-patients-with-favorable-intermediate-risk-localized-prostate-cancer-58160https://curecurrent.com/trials/focused-stereotactic-radiation-treatment-of-prostatic-adenocarcinoma-58161https://curecurrent.com/trials/cyberknife-for-prostate-cancer-patients-aged-70-y-or-more-58162https://curecurrent.com/trials/quantitative-mpmri-to-predict-metastatic-potential-of-prostate-cancer-58163https://curecurrent.com/trials/apalutamide-and-leuprolide-in-intermediate-and-high-risk-prostate-cancer-58164https://curecurrent.com/trials/hormone-therapy-and-radiation-therapy-or-hormone-therapy-and-radiation-therapy-followed-by-docetaxel-and-prednisone-in-t-58165https://curecurrent.com/trials/mri-for-assessment-of-hypoxia-induced-prostate-cancer-aggressiveness-58166https://curecurrent.com/trials/ultrasound-guided-implant-radiation-therapy-in-treating-patients-with-locally-recurrent-prostate-cancer-previously-treat-58167https://curecurrent.com/trials/optimizing-positive-predicting-value-of-prostate-mri-58168https://curecurrent.com/trials/hydroxychloroquine-in-treating-patients-with-rising-psa-levels-after-local-therapy-for-prostate-cancer-58169https://curecurrent.com/trials/hormone-therapy-and-radiation-therapy-in-treating-patients-with-prostate-cancer-58170https://curecurrent.com/trials/radiation-therapy-with-or-without-bicalutamide-for-recurrent-pt3n0-prostate-cancer-after-radical-prostatectomy-58171https://curecurrent.com/trials/mri-assisted-focal-boost-with-hdr-monotherapy-for-prostate-cancer-patients-58172https://curecurrent.com/trials/transrectal-photoacoustic-imaging-of-the-prostate-58173https://curecurrent.com/trials/stereotactic-mri-guided-radiation-for-localized-prostate-cancer-58174https://curecurrent.com/trials/a-trial-of-177lu-psma617-theranostic-versus-cabazitaxel-in-progressive-metastatic-castration-resistant-prostate-cancer-58175https://curecurrent.com/trials/hypofractionated-expedited-radiotherapy-for-men-with-localised-prostate-cancer-58176https://curecurrent.com/trials/prospective-prolaris-value-and-efficacy-58177https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-prostate-cancer-58178https://curecurrent.com/trials/prostate-cancer-detection-screening-mri-protocol-58179https://curecurrent.com/trials/prostate-cancer-biobank-58180https://curecurrent.com/trials/clinical-and-quality-of-life-outcomes-after-open-or-robotic-assisted-laparoscopic-radical-prostatectomy-58181https://curecurrent.com/trials/quadratus-lumborum-block-vs-transversus-abdominis-plane-block-for-post-prostatectomy-analgesia-58182https://curecurrent.com/trials/comparison-h-fire-and-laparoscopic-rp-in-treating-men-with-localized-prostate-cancer-58183https://curecurrent.com/trials/the-relationship-between-serum-psa-levels-and-wbc-delta-neutrophil-index-dni-and-other-hematological-parameters-58184https://curecurrent.com/trials/cabazitaxel-versus-the-switch-to-alternative-ar-targeted-agent-enzalutamide-or-abiraterone-in-metastatic-castration-resi-58185https://curecurrent.com/trials/immune-profiling-after-hdr-in-local-relapsed-prostate-cancer-58186https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-axumin-pet-ct-for-risk-stratification-for-prostate-cancer-58187https://curecurrent.com/trials/japanese-research-for-patients-with-non-metastatic-castration-resistant-prostate-cancer-enzalutamide-58188https://curecurrent.com/trials/men-s-prostate-awareness-church-training-58189https://curecurrent.com/trials/virtual-prostate-biopsy-protocol-for-patients-on-active-surveillance-and-at-risk-of-prostate-cancer-58190https://curecurrent.com/trials/radiotherapy-plus-hormone-therapy-in-biochemically-relapsing-prostate-cancer-patients-following-surgery-58191https://curecurrent.com/trials/outcome-of-treatment-of-prostate-cancer-at-sohag-university-hospital-between-2017-to-2021-58192https://curecurrent.com/trials/c-acetate-pet-ct-imaging-to-evaluate-treatment-changes-in-prostate-cancer-58193https://curecurrent.com/trials/toward-a-comprehensive-supportive-care-intervention-for-older-or-frail-men-with-mcrpc-58194https://curecurrent.com/trials/an-rct-to-compare-early-continence-recovery-after-rarp-with-or-without-sustainable-functional-urethral-reconstruction-58195https://curecurrent.com/trials/promoting-shared-decision-making-in-opportunistic-screening-for-prostate-cancer-58196https://curecurrent.com/trials/potency-preservation-in-prostate-cancer-patients-treated-with-ultrasound-guided-low-dose-rate-brachytherapy-58197https://curecurrent.com/trials/efavirenz-in-treating-patients-with-metastatic-prostate-cancer-58198https://curecurrent.com/trials/trial-evaluating-the-safety-of-2-schedules-of-cabazitaxel-in-elderly-men-with-mcrpc-previously-treated-with-a-docetaxel-58199https://curecurrent.com/trials/lu177-eb-psma617-radionuclide-treatment-in-patients-with-metastatic-castration-resistant-prostate-cancer-58200https://curecurrent.com/trials/idronoxil-suppository-combine-with-radiotherapy-for-metastatic-prostate-cancer-58201https://curecurrent.com/trials/prostate-cancer-monitoring-using-18f-dcfpyl-and-blood-based-biomarkers-58202https://curecurrent.com/trials/18f-dcfpyl-positron-emission-tomography-pet-computed-tomography-ct-in-men-with-prostate-cancer-58203https://curecurrent.com/trials/culture-guided-antimicrobial-prophylaxis-in-men-undergoing-prostate-biopsy-58204https://curecurrent.com/trials/slpi-for-prostate-cancer-58205https://curecurrent.com/trials/decision-impact-trial-of-the-exodx-prostate-intelliscore-58206https://curecurrent.com/trials/sipuleucel-t-and-stereotactic-ablative-body-radiation-sabr-for-metastatic-castrate-resistant-prostate-cancer-mcrpc-58207https://curecurrent.com/trials/prediction-model-fo-screening-and-diagnosis-of-prostate-cancer-in-psa-gray-zone-based-on-serum-phi-combined-with-tpv-58208https://curecurrent.com/trials/open-label-phase-i-randomised-double-blind-phase-ii-study-in-mcrpc-of-azd5363-in-combination-with-dp-chemotherapy-58209https://curecurrent.com/trials/molecular-imaging-of-prostate-cancer-using-radiofluorinated-psma-ligand-58210https://curecurrent.com/trials/anxiety-in-black-men-with-prostate-cancer-validation-of-the-memorial-anxiety-scale-for-prostate-cancer-in-an-sample-of-b-58211https://curecurrent.com/trials/novel-imaging-in-staging-of-primary-prostate-cancer-58212https://curecurrent.com/trials/biodistribution-and-dosimetry-of-ga-68-p16-093-in-prostate-cancer-58213https://curecurrent.com/trials/bariatric-arterial-embolization-for-men-starting-hormones-for-prostate-cancer-58214https://curecurrent.com/trials/prosaic-ds-study-prostate-ai-in-cancer-decision-support-58215https://curecurrent.com/trials/clinical-study-of-psma-targeted-car-t-cells-in-the-treatment-of-castration-resistant-prostate-cancer-58216https://curecurrent.com/trials/radio-guided-lymph-node-dissection-in-oligometastatic-prostate-cancer-patients-58217https://curecurrent.com/trials/psma-pet-ct-vs-mpmri-in-patients-with-a-high-suspicion-of-prostate-cancer-a-head-to-head-parallel-prospective-trial-58218https://curecurrent.com/trials/sephb4-hsa-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-58219https://curecurrent.com/trials/hyperpolarized-c-13-pyruvate-as-a-biomarker-in-patients-with-advanced-solid-tumor-malignancies-58220https://curecurrent.com/trials/study-of-the-response-to-irradiation-on-prostatic-explants-ex-vivo-as-a-predictive-factor-of-the-clinical-response-to-ir-58221https://curecurrent.com/trials/neoadjuvant-pembrolizumab-plus-androgen-axis-blockade-prior-to-prostatectomy-for-high-risk-localized-prostate-cancer-58222https://curecurrent.com/trials/enzalutamide-leuprolide-abiraterone-pred-in-prostate-58223https://curecurrent.com/trials/exercise-during-active-surveillance-for-prostate-cancer-58224https://curecurrent.com/trials/optimal-sequencing-of-treatment-options-for-poor-risk-mcrpc-previously-treated-with-docetaxel-58225https://curecurrent.com/trials/registry-of-treatment-outcomes-of-symptomatic-metastasized-castration-resistant-prostate-cancer-treated-with-radium-223-58226https://curecurrent.com/trials/pet-ct-and-wb-mri-for-staging-and-response-in-crpc-patients-receiving-enzalutamide-58227https://curecurrent.com/trials/imaging-staging-and-response-prediction-in-metastatic-hormono-sensitive-prostate-cancer-patients-receiving-enzalutamide-58228https://curecurrent.com/trials/sakk-08-15-promet-salvage-radiotherapy-metformin-for-patients-with-prostate-cancer-after-prostatectomy-58229https://curecurrent.com/trials/pamiparib-in-mcrpc-with-hrd-or-brca1-2-mutation-58230https://curecurrent.com/trials/ds-titanium-ligation-clip-in-urology-prostatectomy-and-nephrectomy-58231https://curecurrent.com/trials/inject-a-pilot-study-of-intra-tumoral-injections-in-metastatic-urological-cancers-58232https://curecurrent.com/trials/neoadjuvant-hormone-and-radiation-therapy-followed-by-radical-prostatectomy-in-patients-with-high-risk-prostate-cancer-58233https://curecurrent.com/trials/pet-mri-for-men-being-considered-for-radiotherapy-for-suspected-prostate-cancer-recurrence-post-prostatectomy-58234https://curecurrent.com/trials/embr-thermal-device-for-hot-flash-management-in-prostate-cancer-58235https://curecurrent.com/trials/active-surveillance-in-prostate-cancer-58236https://curecurrent.com/trials/fluciclovine-axumin-pet-ct-vs-naf-pet-ct-in-prostate-cancer-osseous-metastatic-disease-58237https://curecurrent.com/trials/epix-a-study-to-gather-more-information-about-characteristics-of-patients-and-other-factors-which-may-contribute-to-surv-58238https://curecurrent.com/trials/white-button-mushroom-extract-in-treating-patients-with-recurrent-prostate-cancer-after-local-therapy-58239https://curecurrent.com/trials/exodx-prostate-evaluation-in-prior-negative-prostate-biopsy-setting-58240https://curecurrent.com/trials/surgery-versus-radiotherapy-for-locally-advanced-prostate-cancer-58241https://curecurrent.com/trials/maintaining-suppression-of-testosterone-with-transdermal-estradiol-gel-58242https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-switching-from-zoladex-monthly-or-quarterly-to-eligard-semiannual-58243https://curecurrent.com/trials/bicalutamide-with-or-without-metformin-for-biochemical-recurrence-in-overweight-or-obese-prostate-cancer-patients-58244https://curecurrent.com/trials/trial-of-nanopac-focal-therapy-for-prostate-cancer-58245https://curecurrent.com/trials/performance-of-prostate-mri-and-following-biopsy-to-detect-prostate-cancer-recurrence-after-focal-therapy-58246https://curecurrent.com/trials/advanced-prostate-imaging-of-recurrent-cancer-after-radiotherapy-58247https://curecurrent.com/trials/cabozantinib-and-androgen-ablation-in-patients-with-androgen-dependent-metastatic-prostate-cancer-58248https://curecurrent.com/trials/phase-ii-laser-focal-therapy-of-prostate-cancer-58249https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-sabr-for-low-risk-prostate-cancer-with-injectable-rectal-spacer-58250https://curecurrent.com/trials/recalled-international-index-of-erectile-function-5-collected-post-prostatectomy-in-assessing-preop-erectile-function-58251https://curecurrent.com/trials/comparative-analysis-of-transperineal-versus-transrectal-approaches-for-mri-targeted-biopsy-of-the-prostate-for-the-dete-58252https://curecurrent.com/trials/multi-epitope-tarp-peptide-autologous-dendritic-cell-vaccination-in-men-with-stage-d0-prostate-cancer-58253https://curecurrent.com/trials/64cu-sar-bispsma-positron-emission-tomography-of-patients-with-known-or-suspected-prostate-cancer-58254https://curecurrent.com/trials/mr-simulation-in-radiotherapy-for-prostate-cancer-58255https://curecurrent.com/trials/functional-mr-guided-stereotactic-body-radiation-therapy-of-prostate-cancer-58256https://curecurrent.com/trials/hdr-brachytherapy-as-monotherapy-for-low-and-intermediate-risk-prostate-cancer-58257https://curecurrent.com/trials/hypofractionated-radiotherapy-versus-stereotactic-irradiation-with-hyaluronic-acid-58258https://curecurrent.com/trials/enhanced-systemic-combined-with-local-treatment-for-primary-and-metastatic-lesions-in-oligo-metastatic-prostate-cancer-58259https://curecurrent.com/trials/intravesical-prostatic-protrusion-mimicking-urothelial-cell-carcinoma-of-the-bladder-58260https://curecurrent.com/trials/evaluation-of-the-pi-rads-v2-1-score-using-multiple-readers-58261https://curecurrent.com/trials/expanded-access-protocol-of-68ga-psma-11-pet-imaging-of-prostate-cancer-58262https://curecurrent.com/trials/glycosylation-of-exosomes-in-prostate-and-urothelial-carcinoma-58263https://curecurrent.com/trials/evaluation-of-fapi-pet-in-prostate-cancer-58264https://curecurrent.com/trials/development-of-diagnostics-and-treatment-of-urological-cancers-58265https://curecurrent.com/trials/feasibility-of-mri-workflow-alone-in-external-radiotherapy-for-the-treatment-of-brain-and-prostate-tumors-58266https://curecurrent.com/trials/using-serum-parathyroid-hormones-and-calcium-to-improve-prostate-cancer-diagnosis-58267https://curecurrent.com/trials/a-prospective-trial-on-nerve-sparing-techniques-performed-in-radical-prostatectomy-58268https://curecurrent.com/trials/collection-of-serum-samples-in-studying-emotional-stress-in-patients-with-prostate-cancer-58269https://curecurrent.com/trials/adaptation-of-an-ehealth-web-application-platform-for-delivery-of-a-sedentary-behavior-intervention-among-prostate-cance-58270https://curecurrent.com/trials/stereotactic-radiotherapy-for-oligometastatic-prostate-cancer-58271https://curecurrent.com/trials/neoadjuvant-weekly-ixabepilone-for-high-risk-clinically-localized-prostate-cancer-58272https://curecurrent.com/trials/hypofractionated-boost-vs-conventionally-fractionated-boost-for-localized-high-risk-prostate-cancer-58273https://curecurrent.com/trials/a-registry-for-patients-treated-on-the-clinical-trial-tax-3503-58274https://curecurrent.com/trials/an-open-label-phase-ii-study-of-biweekly-docetaxel-plus-androgen-deprivation-therapy-in-patients-with-previously-untreat-58275https://curecurrent.com/trials/development-and-evaluation-of-a-therapeutic-education-intervention-in-prostate-cancer-patients-treated-with-radical-pros-58276https://curecurrent.com/trials/comparative-study-of-abiraterone-acetate-tablets-i-or-zytiga-in-patients-with-metastatic-castration-resistant-prostate-c-58277https://curecurrent.com/trials/cabazitaxel-and-radiation-for-patients-with-prostate-cancer-58278https://curecurrent.com/trials/68ga-psma-11-pet-mri-in-finding-tumors-in-patients-with-intermediate-or-high-risk-prostate-cancer-undergoing-surgery-58279https://curecurrent.com/trials/med-diet-prevention-metabolic-syndrome-men-undergoing-androgen-deprivation-therapy-prostate-cancer-58280https://curecurrent.com/trials/low-dose-naltrexone-for-metastatic-melanoma-castrate-resistant-prostate-cancer-and-renal-cancer-58281https://curecurrent.com/trials/calcitriol-or-placebo-in-men-for-prostate-cancer-active-surveillance-58282https://curecurrent.com/trials/the-study-of-olaparib-in-newly-diagnosed-mcrpc-patients-with-hrr-gene-mutation-58283https://curecurrent.com/trials/eribulin-mesylate-administered-in-combination-with-gemcitabine-plus-cisplatin-versus-gemcitabine-plus-cisplatin-alone-as-58284https://curecurrent.com/trials/feasibility-of-the-lum-imaging-system-for-detection-of-prostate-cancer-58285https://curecurrent.com/trials/phase-i-study-mr-guided-sbrt-to-pca-58286https://curecurrent.com/trials/a-study-of-cetrelimab-jnj-63723283-a-programmed-cell-death-receptor-1-pd-1-inhibitor-administered-in-combination-with-ap-58287https://curecurrent.com/trials/impact-of-robot-assisted-radical-prostatectomy-technique-on-short-term-continence-recovery-58288https://curecurrent.com/trials/study-of-dasatinib-androgen-deprivation-therapy-and-radiation-58289https://curecurrent.com/trials/prostate-biopsy-access-needle-needle-guide-feasibility-study-58290https://curecurrent.com/trials/clinical-validation-of-the-prognostic-value-of-the-prts-on-prostate-cancer-patients-58291https://curecurrent.com/trials/ultralow-versus-standard-pneumoperitoneum-pressure-58292https://curecurrent.com/trials/sorafenib-and-docetaxel-in-patients-with-prostate-cancer-that-did-not-respond-to-previous-hormone-therapy-58293https://curecurrent.com/trials/radium-223-in-castrate-resistant-prostate-cancer-bone-metastases-58294https://curecurrent.com/trials/observational-study-of-docetaxel-exposure-in-metastatic-prostate-cancer-patients-58295https://curecurrent.com/trials/miprostate-information-hub-for-the-prostate-cancer-care-flow-58296https://curecurrent.com/trials/soy-derivatives-for-control-of-hot-flashes-in-men-on-androgen-deprivation-therapy-58297https://curecurrent.com/trials/treatment-of-metastatic-castrate-resistant-prostate-cancer-patients-according-to-circulating-tumor-cells-kinetic-58298https://curecurrent.com/trials/reduction-of-prostate-biopsy-morbidity-58299https://curecurrent.com/trials/the-immuno-response-to-primary-cryotherapy-for-the-treatment-of-prostate-cancer-58300https://curecurrent.com/trials/sbrt-for-organ-confined-prostate-cancer-58301https://curecurrent.com/trials/retzius-sparing-technique-in-robotic-assisted-radical-prostatectomy-58302https://curecurrent.com/trials/medical-economics-of-urinary-pca3-test-for-prostate-cancer-diagnosis-58303https://curecurrent.com/trials/biomarker-driven-therapy-with-nivolumab-and-ipilimumab-in-treating-patients-with-metastatic-hormone-resistant-prostate-c-58304https://curecurrent.com/trials/race-related-alternative-splicing-novel-targets-in-prostate-cancer-58305https://curecurrent.com/trials/mr-image-guided-therapy-in-prostate-cancer-58306https://curecurrent.com/trials/prostate-cancer-screening-trial-using-imaging-58307https://curecurrent.com/trials/electrical-patient-reported-outcome-of-prostate-cancer-radiotherapy-58308https://curecurrent.com/trials/impact-of-adjuvant-statin-therapy-in-patients-who-underwent-radical-prostatectomy-for-locally-advanced-prostate-cancer-58309https://curecurrent.com/trials/pca-patients-managed-with-adt-to-examine-the-effect-of-nutritional-guidance-and-aerobic-resistance-fitness-training-58310https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-for-prostate-cancer-58311https://curecurrent.com/trials/expanded-access-ga-68-psma-11-pet-imaging-58312https://curecurrent.com/trials/f18-dcfpyl-pet-ct-in-imaging-participants-with-recurrent-prostate-cancer-58313https://curecurrent.com/trials/prostatic-cancer-versus-androgen-deficiency-58314https://curecurrent.com/trials/impact-of-yoga-as-complementary-therapy-in-patients-undergoing-radical-prostatectomy-58315https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-relugolix-in-men-with-advanced-prostate-cancer-58316https://curecurrent.com/trials/68ga-psma-pet-ct-in-detecting-prostate-cancer-recurrence-in-patients-with-elevated-psa-after-initial-treatment-58317https://curecurrent.com/trials/a-phase-ii-neoadjuvant-study-of-apalutamide-abiraterone-acetate-prednisone-degarelix-and-indomethacin-in-men-with-locali-58318https://curecurrent.com/trials/a-study-to-learn-about-the-awareness-and-knowledge-that-doctors-have-about-the-safety-and-safe-use-information-for-andro-58319https://curecurrent.com/trials/analysis-of-next-generation-pet-and-liquid-biopsy-to-monitor-mcrpc-treated-with-abiraterone-angela-trial-58320https://curecurrent.com/trials/hormone-suppression-and-radiation-therapy-for-6-months-with-without-docetaxel-for-high-risk-prostate-cancer-58321https://curecurrent.com/trials/bcl-xl-42-caf09b-vaccination-for-patients-with-prostate-cancer-with-lymph-node-metastases-58322https://curecurrent.com/trials/a-study-to-assess-mitomic-prostate-test-for-prostate-cancer-screening-58323https://curecurrent.com/trials/crizotinib-in-combination-with-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-58324https://curecurrent.com/trials/study-of-external-beam-radiation-therapy-with-and-without-hormonal-therapy-to-treat-prostate-cancer-58325https://curecurrent.com/trials/radiolabeled-gallium-68-68ga-psma-for-pet-ct-imaging-to-detect-prostate-cancer-58326https://curecurrent.com/trials/the-translate-trial-58327https://curecurrent.com/trials/spermine-measuring-device-evaluation-protocol-58328https://curecurrent.com/trials/a-study-of-pharmacodynamic-and-genetic-parameters-of-abira-des-study-participants-nct02217566-participants-with-metastat-58329https://curecurrent.com/trials/descriptive-analysis-of-clinical-outcomes-in-patients-with-prostate-gland-cancer-which-spreads-to-other-parts-of-the-bod-58330https://curecurrent.com/trials/implant-radiation-therapy-or-surgery-in-treating-patients-with-prostate-cancer-58331https://curecurrent.com/trials/open-radical-prostatectomy-and-erector-spinae-plane-block-58332https://curecurrent.com/trials/assessment-of-new-molecular-imaging-strategies-for-prostate-cancer-58333https://curecurrent.com/trials/transperineal-laser-ablation-treatment-tpla-for-prostate-cancer-pca-registry-58334https://curecurrent.com/trials/innovative-planning-and-guidance-system-for-prostate-focal-brachytherapy-58335https://curecurrent.com/trials/the-effect-of-androgen-deprivation-therapy-on-gut-and-urinary-microbiota-in-patients-with-prostate-cancer-58336https://curecurrent.com/trials/vinflunine-in-hormone-refractory-prostate-cancer-hrpc-58337https://curecurrent.com/trials/a-trial-to-evaluate-safety-of-firmagon-degarelix-in-indian-patients-diagnosed-with-advanced-hormone-dependent-prostate-c-58338https://curecurrent.com/trials/test-retest-reproducibility-of-18f-dcfpyl-pet-ct-in-the-evaluation-of-patients-with-metastatic-prostate-cancer-58339https://curecurrent.com/trials/study-of-18f-dcfpyl-pet-ct-imaging-in-patients-with-prostate-cancer-58340https://curecurrent.com/trials/a-comparison-of-aerobic-and-resistance-exercise-to-counteract-treatment-side-effects-in-men-with-prostate-cancer-58341https://curecurrent.com/trials/tqb3616-capsules-combined-with-abiraterone-acetate-plus-prednisone-in-metastatic-castration-resistant-prostate-cancer-58342https://curecurrent.com/trials/prevalence-of-hrr-related-genes-mutations-and-prognosis-in-metastatic-castration-resistant-prostate-cancer-mcrpc-patient-58343https://curecurrent.com/trials/transperineal-mri-trus-fusion-guided-prostate-biopsy-with-vs-without-antibiotic-prophylaxis-58344https://curecurrent.com/trials/68ga-htk03149-for-use-as-a-diagnostic-radiopharmaceutical-58345https://curecurrent.com/trials/study-of-veru-944-to-ameliorate-hot-flashes-in-men-with-advanced-prostate-cancer-58346https://curecurrent.com/trials/acmella-oleracea-in-the-analgesia-of-the-digital-rectal-examination-58347https://curecurrent.com/trials/study-to-gather-information-how-often-venous-thromboembolism-occurs-in-prostate-cancer-patients-in-sweden-and-how-this-c-58348https://curecurrent.com/trials/a-study-of-zen003694-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer-58349https://curecurrent.com/trials/study-of-carbon-dioxide-exchange-patterns-during-robotic-prostatectomies-58350https://curecurrent.com/trials/clinical-study-of-noni-extract-in-men-with-very-low-risk-or-low-risk-prostate-cancer-58351https://curecurrent.com/trials/sephb4-hsa-before-surgery-in-treating-patients-with-bladder-cancer-prostate-cancer-or-kidney-cancer-58352https://curecurrent.com/trials/68ga-psma-pet-ct-imaging-in-assessment-of-prostate-cancer-58353https://curecurrent.com/trials/neoadjuvant-prostvac-vf-with-or-without-ipilimumab-for-prostate-cancer-58354https://curecurrent.com/trials/connected-catheter-safety-and-effectiveness-study-58355https://curecurrent.com/trials/bpmri-and-risk-based-shared-clinical-decision-making-in-prostate-cancer-diagnosis-58356https://curecurrent.com/trials/bruog-263-prostate-specific-membrane-antigen-psma-glioblastoma-multiforme-gbm-58357https://curecurrent.com/trials/a-study-to-evaluate-serum-testosterone-levels-in-patients-with-metastatic-castration-resistant-prostate-cancer-58358https://curecurrent.com/trials/carbon-ion-radiotherapy-for-the-treatment-of-localized-prostate-cancer-58359https://curecurrent.com/trials/phase-ii-study-of-sbrt-as-treatment-for-oligometastases-in-prostate-cancer-58360https://curecurrent.com/trials/12-fractions-carbon-ion-radiotherapy-for-localized-prostate-cancer-58361https://curecurrent.com/trials/3-arm-study-of-abiraterone-acetate-alone-abiraterone-acetate-plus-degarelix-a-gnrh-antagonist-and-degarelix-alone-for-pa-58362https://curecurrent.com/trials/one-year-open-extension-to-evaluate-the-treatment-of-patients-with-castration-resistant-prostate-cancer-with-yonsa-58363https://curecurrent.com/trials/the-prognostic-role-of-lymph-node-dissection-in-men-with-prostate-cancer-treated-with-radical-prostatectomy-58364https://curecurrent.com/trials/treatment-of-metastatic-castration-resistant-prostate-cancer-with-homologous-recombination-deficiency-58365https://curecurrent.com/trials/functional-image-guided-carbon-ion-irradiation-with-simultaneous-integrated-boost-for-prostate-cancer-58366https://curecurrent.com/trials/phase-1-trial-of-pan-301-1-sns-301-in-cancer-patients-58367https://curecurrent.com/trials/pembrolizumab-and-cryosurgery-in-treating-patients-with-newly-diagnosed-oligo-metastatic-prostate-cancer-58368https://curecurrent.com/trials/studying-genes-environment-and-prostate-cancer-risk-in-patients-with-or-without-prostate-cancer-58369https://curecurrent.com/trials/dose-finding-safety-study-of-val201-in-cancer-patients-58370https://curecurrent.com/trials/intravesical-antifibrinolytic-for-patients-with-hematuria-and-clot-retention-58371https://curecurrent.com/trials/carbon-ion-followed-by-proton-radiotherapy-for-prostate-cancer-with-pelvic-lymph-nodes-metastases-58372https://curecurrent.com/trials/a-clinical-trial-of-adnrgm-plus-cb1954-in-prostate-cancer-58373https://curecurrent.com/trials/non-interventional-study-with-ra-223-dichloride-assessing-overall-survival-and-effectiveness-predictors-for-mcrpc-patien-58374https://curecurrent.com/trials/pain-evaluation-in-radium-223-treated-castration-resistant-prostate-cancer-patients-with-bone-metastases-58375https://curecurrent.com/trials/photoacoustic-imaging-pai-of-the-prostate-a-clinical-feasibility-study-58376https://curecurrent.com/trials/organoids-from-metastases-of-prostate-cancer-58377https://curecurrent.com/trials/s0421-docetaxel-and-prednisone-with-or-without-atrasentan-in-treating-patients-with-stage-iv-prostate-cancer-and-bone-me-58378https://curecurrent.com/trials/cholecalciferol-supplement-in-treating-patients-with-localized-prostate-cancer-undergoing-observation-58379https://curecurrent.com/trials/a-phase-1-study-of-is-002-injection-in-patients-undergoing-robotic-prostatectomy-58380https://curecurrent.com/trials/gallium-68-psma-11-positron-emission-tomography-pet-imaging-in-patients-with-biochemical-recurrence-58381https://curecurrent.com/trials/penile-length-maintenance-post-prostatectomy-58382https://curecurrent.com/trials/optimizing-the-effectiveness-of-routine-post-treatment-surveillance-in-prostate-cancer-survivors-58383https://curecurrent.com/trials/modradoc006-r-in-metastatic-castration-resistant-prostate-cancer-58384https://curecurrent.com/trials/a-study-of-68ga-grp-pet-ct-for-imaging-in-low-and-intermediate-risk-prostate-cancer-58385https://curecurrent.com/trials/studying-repeated-dce-mri-and-dwi-in-patients-diagnosed-with-prostate-cancer-58386https://curecurrent.com/trials/transperineal-laser-ablation-for-focal-treatment-of-prostate-cancer-58387https://curecurrent.com/trials/aneustat-treatment-of-localized-prostate-cancer-under-active-surveillance-58388https://curecurrent.com/trials/neoadjuvant-dupilumab-in-men-with-localized-high-risk-prostate-cancer-58389https://curecurrent.com/trials/undistort-correction-of-distortions-in-diffusion-mri-v1-0-58390https://curecurrent.com/trials/reimagine-prostate-cancer-screening-58391https://curecurrent.com/trials/avelumab-with-bempegaldesleukin-with-or-without-talazoparib-or-enzalutamide-in-advanced-or-metastatic-solid-tumors-58392https://curecurrent.com/trials/whole-body-diffusion-weighted-magnetic-resonance-imaging-mri-as-a-response-biomarker-for-metastatic-prostate-cancer-58393https://curecurrent.com/trials/music-listening-as-a-postanesthesia-care-unit-pacu-nursing-intervention-58394https://curecurrent.com/trials/neoadjuvant-therapy-with-proxalutamide-combined-with-androgen-deprivation-therapy-adt-for-high-risk-prostate-cancer-58395https://curecurrent.com/trials/trial-of-an-online-multimedia-program-to-boost-coping-function-for-prostate-cancer-survivors-progress-58396https://curecurrent.com/trials/trial-of-radiotherapy-with-leuprolide-and-enzalutamide-in-high-risk-prostate-cancer-58397https://curecurrent.com/trials/radiologically-guided-biopsies-of-mcrpc-58398https://curecurrent.com/trials/a-pilot-study-to-assess-the-immunogenicity-of-candidate-psa-peptides-for-a-prostate-cancer-vaccine-58399https://curecurrent.com/trials/low-dose-neuroleptanalgesia-for-postoperative-delirium-in-elderly-patients-58400https://curecurrent.com/trials/the-wolverhampton-assessment-tool-a-tool-for-patient-reported-wellbeing-in-the-context-of-prostate-cancer-58401https://curecurrent.com/trials/study-to-assess-safety-and-tolerability-of-oral-cc-115-for-patients-with-advanced-solid-tumors-and-hematologic-malignanc-58402https://curecurrent.com/trials/international-multi-center-open-label-randomized-study-assessing-the-safety-and-efficacy-of-a-monthly-dosing-regimen-of-58403https://curecurrent.com/trials/targeted-radiotherapy-for-recurrent-prostate-cancer-58404https://curecurrent.com/trials/postoperative-pain-control-for-prostatectomy-58405https://curecurrent.com/trials/sirolimus-docetaxel-and-carboplatin-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-58406https://curecurrent.com/trials/clinical-evaluation-of-exodx-prostate-intelliscore-in-men-presenting-for-initial-prostate-biopsy-58407https://curecurrent.com/trials/68ga-psma-11-pet-ct-scan-in-impacting-treatment-strategies-for-patients-with-prostate-cancer-58408https://curecurrent.com/trials/ga-68-psma-11-pet-ct-in-patients-with-biochemical-recurrence-of-prostate-cancer-digital-pet-ct-versus-analog-pet-ct-58409https://curecurrent.com/trials/study-of-rv001v-in-biochemical-failure-following-curatively-intended-therapy-for-localized-prostate-cancer-58410https://curecurrent.com/trials/soy-protein-effexor-hormone-therapy-for-prostate-cancer-58411https://curecurrent.com/trials/a-selective-androgen-receptor-modulator-for-symptom-management-in-prostate-cancer-58412https://curecurrent.com/trials/l-arginine-supplementation-with-or-without-enzyme-inhibitors-treating-erectile-function-of-prostate-cancer-survivors-58413https://curecurrent.com/trials/assessment-of-primary-androgen-deprivation-therapy-for-non-metastatic-prostate-cancer-among-elderly-58414https://curecurrent.com/trials/exercise-intervention-among-men-with-prostate-cancer-initiating-androgen-deprivation-therapy-58415https://curecurrent.com/trials/perioperative-atezolizumab-with-mva-bn-brachyury-and-prostvac-for-intermediate-risk-and-high-risk-localized-prostate-can-58416https://curecurrent.com/trials/how-does-prostate-cancer-metastasize-studying-the-role-of-secreted-packages-exosomes-from-fat-tissue-in-lean-and-obese-p-58417https://curecurrent.com/trials/mri-guided-focal-laser-ablation-58418https://curecurrent.com/trials/tailored-web-based-psychosocial-and-physical-activity-self-management-programme-58419https://curecurrent.com/trials/metabolic-change-in-prostate-cancer-bone-metastases-on-68ga-hbed-cc-psma-pet-ct-following-radium-223-therapy-58420https://curecurrent.com/trials/scap-vs-hifu-for-recurrent-prostate-cancer-after-radiation-therapy-58421https://curecurrent.com/trials/postoperative-prognosis-management-service-based-mhealth-for-colon-cancer-patients-58422https://curecurrent.com/trials/comparative-study-of-alternative-antiandrogen-aa-therapy-and-early-initiating-of-enzalutamide-for-castration-resistant-p-58423https://curecurrent.com/trials/testing-the-synergism-of-phytonutrients-curcumin-and-ursolic-acid-to-target-molecular-pathways-in-the-prostate-58424https://curecurrent.com/trials/a-phase-ib-study-of-intravenous-copper-loading-with-oral-disulfiram-in-metastatic-castration-resistant-prostate-cancer-58425https://curecurrent.com/trials/safety-and-feasibility-of-reversible-induction-strategy-58426https://curecurrent.com/trials/the-combination-therapy-with-ra-223-and-enzalutamide-58427https://curecurrent.com/trials/positron-emission-tomography-magnetic-resonance-imaging-pet-mri-guided-biopsy-in-men-with-elevated-psa-58428https://curecurrent.com/trials/human-prostate-tissue-model-to-maintain-and-study-prostate-cancer-stem-cells-58429https://curecurrent.com/trials/comprehensive-lifestyle-improvement-program-for-men-with-prostate-cancer2-clipp2-58430https://curecurrent.com/trials/phase-1-1b-study-to-evaluate-the-safety-and-tolerability-of-ciforadenant-alone-and-in-combination-with-atezolizumab-in-a-58431https://curecurrent.com/trials/measurements-of-sexual-steroids-concentrations-in-prostatic-tissue-58432https://curecurrent.com/trials/psma-guided-approach-for-biochemical-relapse-after-prostatectomy-psiche-58433https://curecurrent.com/trials/efficacy-and-safety-of-ly01005-in-patients-with-prostate-cancer-compared-to-zoladex-58434https://curecurrent.com/trials/postoperative-prognosis-management-service-based-mhealth-for-prostate-cancer-patients-58435https://curecurrent.com/trials/robotic-arm-assisted-ga-68-psma-pet-ct-guided-transgluteal-prostate-biopsy-58436https://curecurrent.com/trials/preventing-catheter-related-bladder-discomfort-crbd-with-bilateral-pudendal-nerve-block-58437https://curecurrent.com/trials/nivolumab-in-prostate-cancer-with-dna-repair-defects-immunoprost-trial-58438https://curecurrent.com/trials/gallium-68-psma-11-pet-imaging-in-prostate-cancer-patients-58439https://curecurrent.com/trials/177lu-j591-and-177lu-psma-617-combination-for-mcrpc-58440https://curecurrent.com/trials/cabazitaxel-in-mcrpc-patients-with-ar-v7-positive-circulating-tumor-cells-ctcs-58441https://curecurrent.com/trials/sipuleucel-t-with-immediate-vs-delayed-cytotoxic-t-lymphocyte-associated-protein-4-ctla-4-blockade-for-prostate-cancer-58442https://curecurrent.com/trials/early-rising-psa-endocrine-treatment-versus-chemo-endocrine-therapy-spcg14-58443https://curecurrent.com/trials/preference-based-exercise-rct-for-men-with-pc-on-adt-58444https://curecurrent.com/trials/study-evaluating-sodium-selenite-in-combination-with-abiraterone-in-castrate-resistant-prostate-cancer-progressing-on-ab-58445https://curecurrent.com/trials/impact-of-exercise-on-prognostic-biomarkers-related-to-prostate-cancer-58446https://curecurrent.com/trials/perioperative-post-prostatectomy-incontinence-home-telehealth-program-58447https://curecurrent.com/trials/study-of-18f-dcfpyl-pet-ct-imaging-in-patients-with-prostate-cancer-58448https://curecurrent.com/trials/health-related-quality-of-life-psychological-distress-and-fatigue-in-metastatic-crpc-patients-treated-with-radium-223-58449https://curecurrent.com/trials/focal-prostate-radio-frequency-ablation-58450https://curecurrent.com/trials/xl-184-abiraterone-in-post-chemo-crpc-58451https://curecurrent.com/trials/docetaxel-and-carboplatin-for-patients-with-mcrpc-and-dna-repair-deficiencies-58452https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-receiving-sipuleucel-t-58453https://curecurrent.com/trials/administration-of-antibiotic-prophylaxis-for-transperineal-prostate-biopsy-in-cipto-mangunkusumo-hospital-58454https://curecurrent.com/trials/quality-of-life-following-radical-prostatectomy-58455https://curecurrent.com/trials/cabozantinib-s-malate-in-treating-patients-with-hormone-resistant-metastatic-prostate-cancer-58456https://curecurrent.com/trials/intensity-modulated-radiation-therapy-imrt-radiotherapy-for-treating-prostate-pelvic-nodes-58457https://curecurrent.com/trials/combination-of-entinostat-and-enzalutamide-in-advanced-prostate-cancer-58458https://curecurrent.com/trials/cabazitaxel-with-or-without-carboplatin-in-treating-patients-with-previously-treated-metastatic-castration-resistant-pro-58459https://curecurrent.com/trials/optimization-of-the-core-number-and-location-for-targeted-prostate-biopsy-58460https://curecurrent.com/trials/psma-pet-ct-for-biochemical-recurrence-detection-in-patients-with-prostate-cancer-58461https://curecurrent.com/trials/improving-diagnosis-and-treatment-of-metastatic-advanced-prostate-cancer-58462https://curecurrent.com/trials/a-survivorship-care-plan-and-embedded-navigation-tool-58463https://curecurrent.com/trials/assessment-of-vmcore-biopsy-versus-standard-of-care-biopsy-58464https://curecurrent.com/trials/androgen-deprivation-therapy-on-bone-mineral-density-change-in-prostate-cancer-patients-58465https://curecurrent.com/trials/living-well-on-androgen-deprivation-therapy-58466https://curecurrent.com/trials/the-role-of-ga68-psma-11-pet-imaging-in-prostate-cancer-patients-undergoing-androgen-deprivation-therapy-58467https://curecurrent.com/trials/improvement-of-communicational-skills-between-health-workers-and-oncological-patients-during-medical-consultative-conver-58468https://curecurrent.com/trials/post-marketing-surveillance-regarding-efficacy-and-safety-of-spaceoar-58469https://curecurrent.com/trials/pyl-in-patients-with-high-risk-and-biochemically-recurrent-prostate-cancer-58470https://curecurrent.com/trials/f-18-fluorocholine-pet-ct-and-mr-imaging-spectroscopy-in-the-management-of-primary-and-recurrent-prostate-cancer-58471https://curecurrent.com/trials/efficacy-and-safety-assessment-of-ire-of-localized-prostate-cancer-58472https://curecurrent.com/trials/active-surveillance-for-low-risk-prostate-cancer-58473https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-and-safety-between-br9004-and-br9004-1-in-healthy-male-volunteers-58474https://curecurrent.com/trials/salvage-hdr-for-locally-recurrent-prostate-cancer-58475https://curecurrent.com/trials/high-dose-rate-prostate-brachytherapy-dose-escalation-to-dominant-intra-prostatic-nodule-58476https://curecurrent.com/trials/lateral-prostate-capsule-sparing-versus-nerve-sparing-robot-assisted-radical-cystectomy-orthotopic-ileal-neobladder-for-58477https://curecurrent.com/trials/application-of-dwi-in-diagnosis-of-prostate-cancer-58478https://curecurrent.com/trials/mri-guided-lattice-extreme-ablative-dose-radiotherapy-for-prostate-cancer-58479https://curecurrent.com/trials/lateral-prostate-capsule-sparing-versus-non-nerve-sparing-robot-assisted-radical-cystectomy-orthotopic-ileal-neobladder-58480https://curecurrent.com/trials/study-of-sipuleucel-t-w-or-w-o-radium-223-in-men-with-asymptomatic-or-minimally-symptomatic-bone-mcrpc-58481https://curecurrent.com/trials/mri-ultrasound-fusion-or-cognitive-registration-in-mr-targeted-prostate-biopsy-58482https://curecurrent.com/trials/study-of-abiraterone-acetate-plus-adt-versus-apalutamide-versus-abiraterone-and-apalutamide-in-patients-with-advanced-pr-58483https://curecurrent.com/trials/pilot-study-of-a-catheter-based-ultrasound-hyperthermia-system-58484https://curecurrent.com/trials/gallium-ga-68-labeled-psma-11-pet-ct-in-detecting-recurrent-prostate-cancer-in-patients-after-initial-therapy-58485https://curecurrent.com/trials/gallium-68-prostate-specific-membrane-antigen-pet-in-diagnosing-patients-with-thyroid-cancer-58486https://curecurrent.com/trials/f-18-psma-1007-versus-f-18-fluorocholine-pet-in-patients-with-biochemical-recurrence-58487https://curecurrent.com/trials/advanced-magnetic-resonance-imaging-mri-in-men-with-suspected-prostate-cancer-58488https://curecurrent.com/trials/to-evaluate-the-criteria-for-renewal-of-luteinizing-hormone-releasing-hormone-lhrh-analogue-treatment-in-prostate-cancer-58489https://curecurrent.com/trials/expanded-access-protocol-of-68ga-psma-11-for-pet-imaging-58490https://curecurrent.com/trials/effect-of-quercetin-on-green-tea-polyphenol-uptake-in-prostate-tissue-from-patients-with-prostate-cancer-undergoing-surg-58491https://curecurrent.com/trials/hormone-therapy-in-treating-patients-with-rising-psa-levels-following-radiation-therapy-for-prostate-cancer-58492https://curecurrent.com/trials/efficacy-and-safety-study-of-panobinostat-in-participants-with-metastatic-hormone-refractory-prostate-cancer-58493https://curecurrent.com/trials/provenge-with-or-without-ptvg-hp-dna-booster-vaccine-in-prostate-cancer-58494https://curecurrent.com/trials/evaluation-of-effects-of-estetrol-on-testosterone-suppression-and-quality-of-life-in-prostate-cancer-patients-treated-wi-58495https://curecurrent.com/trials/early-investigation-of-high-precision-radiotherapy-prior-to-commencing-standard-radiotherapy-for-prostate-cancer-58496https://curecurrent.com/trials/study-of-18f-dcfpyl-pet-ct-imaging-in-patients-with-suspected-recurrence-of-prostate-cancer-58497https://curecurrent.com/trials/the-effect-of-metformin-in-patients-with-metastatic-castration-resistant-prostate-cancer-58498https://curecurrent.com/trials/feasibility-study-into-adjustment-of-the-radiation-beam-to-account-for-prostate-motion-during-radiotherapy-58499https://curecurrent.com/trials/prostate-rectal-separation-with-peg-hydrogel-and-its-effect-on-decreasing-rectal-dose-58500https://curecurrent.com/trials/evaluation-of-the-effect-of-endoscopic-urethral-procedures-applied-after-radical-prostatectomy-on-urinary-incontinence-58501https://curecurrent.com/trials/assess-gamma-h2ax-positivity-in-circulating-prostate-cancer-cells-before-and-after-radium-223-58502https://curecurrent.com/trials/assessment-of-3d-transperineal-ultrasound-imaging-w-matrix-array-transducers-in-prostate-radiotherapy-58503https://curecurrent.com/trials/feasibility-of-a-chemotherapy-with-docetaxel-prednisone-for-castration-resistant-metastatic-prostate-cancer-elderly-pati-58504https://curecurrent.com/trials/electronic-post-treatment-surveillance-program-for-prostate-cancer-survivors-ehealth-58505https://curecurrent.com/trials/pomegranate-juice-in-treating-patients-with-recurrent-prostate-cancer-58506https://curecurrent.com/trials/high-intensity-focused-ultrasound-study-58507https://curecurrent.com/trials/fairly-brief-androgen-suppression-and-stereotactic-radiotherapy-for-high-risk-prostate-cancer-protocol-2-58508https://curecurrent.com/trials/exosomal-microrna-in-predicting-the-aggressiveness-of-prostate-cancer-in-chinese-patients-58509https://curecurrent.com/trials/mhealth-electronic-consultation-recording-mencore-in-advanced-prostate-cancer-58510https://curecurrent.com/trials/nutrition-and-prostate-cancer-58511https://curecurrent.com/trials/clinical-study-of-atezolizumab-anti-pd-l1-and-sipuleucel-t-in-patients-with-asymptomatic-or-minimally-symptomatic-metast-58512https://curecurrent.com/trials/study-of-68ga-hbed-psma-pet-ct-and-conventional-imaging-in-occult-biological-relapse-prostate-cancer-58513https://curecurrent.com/trials/docetaxel-prednisone-plus-fractionated-177lu-j591-antibody-for-metastatic-castrate-resistant-prostate-cancer-58514https://curecurrent.com/trials/treatment-of-castration-resistant-prostate-cancer-using-multi-targeted-recombinant-ad5-psa-muc1-brachyury-based-immunoth-58515https://curecurrent.com/trials/whole-body-magnetic-resonance-imaging-study-58516https://curecurrent.com/trials/a-feasibility-study-followed-by-a-randomized-phase-ii-study-of-yoga-for-radiation-therapy-side-effects-in-prostate-cance-58517https://curecurrent.com/trials/salvage-cryotherapy-for-recurrent-prostate-cancer-after-radiation-therapy-58518https://curecurrent.com/trials/68ga-rm2-for-pet-ct-of-gastrin-releasing-peptide-receptor-grpr-expression-in-prostate-cancer-58519https://curecurrent.com/trials/trial-of-nrx-194204-in-castration-and-taxane-resistant-prostate-cancer-58520https://curecurrent.com/trials/abiraterone-acetate-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-58521https://curecurrent.com/trials/prostate-cancer-localization-with-a-multiparametric-magnetic-resonance-mr-approach-58522https://curecurrent.com/trials/use-of-indocyanine-green-during-pelvic-lymph-node-dissection-in-prostate-cancer-58523https://curecurrent.com/trials/a-multi-omics-study-of-metastatic-prostate-cancer-mosmpca-58524https://curecurrent.com/trials/focal-therapy-for-prostate-cancer-58525https://curecurrent.com/trials/a-study-of-enzalutamide-and-ly3023414-in-men-with-prostate-cancer-58526https://curecurrent.com/trials/nbtxr3-nanoparticles-and-ebrt-or-ebrt-with-brachytherapy-in-the-treatment-of-prostate-adenocarcinoma-58527https://curecurrent.com/trials/study-to-compare-capsule-and-liquid-formulations-of-enzalutamide-after-single-dose-administration-under-fasting-conditio-58528https://curecurrent.com/trials/pilot-study-to-evaluate-the-effects-of-a-generic-goserelin-acetate-in-patients-with-prostate-cancer-58529https://curecurrent.com/trials/mbm-02-tempol-for-the-treatment-of-biochemical-recurrent-prostate-cancer-58530https://curecurrent.com/trials/a-single-patient-compassionate-use-of-mbm-02-tempol-for-the-treatment-of-prostate-cancer-58531https://curecurrent.com/trials/early-and-accurate-detection-of-prostate-cancer-in-general-practice-58532https://curecurrent.com/trials/enzalutamide-plus-everolimus-in-men-with-metastatic-castrate-resistant-prostate-cancer-58533https://curecurrent.com/trials/hdr-brachytherapy-vs-sabr-in-early-intermediate-prostate-cancer-58534https://curecurrent.com/trials/gti-2040-docetaxel-and-prednisone-in-treating-patients-with-prostate-cancer-58535https://curecurrent.com/trials/mri-trus-fusion-guided-prostate-biopsy-an-improved-way-to-detect-and-quantify-prostate-cancer-58536https://curecurrent.com/trials/shorter-duration-radiotherapy-to-treat-prostate-cancer-after-removal-of-the-prostate-58537https://curecurrent.com/trials/innovations-in-the-treatment-of-sexual-health-post-prostate-cancer-treatment-comparing-mindfulness-vs-cbt-58538https://curecurrent.com/trials/combined-ldr-boost-and-hdr-whole-gland-58539https://curecurrent.com/trials/a-phase-ii-study-evaluating-the-efficacy-of-enzalutamide-and-the-role-of-arv7-in-metastatic-castration-resistant-prostat-58540https://curecurrent.com/trials/non-contrast-mr-imaging-for-whole-body-cancer-detection-and-characterization-58541https://curecurrent.com/trials/study-in-urology-practices-looking-at-impact-of-oncotypedx-gps-test-on-men-choosing-and-remaining-on-active-surveillance-58542https://curecurrent.com/trials/phase-1-2a-study-of-trc253-an-androgen-receptor-antagonist-in-metastatic-castration-resistant-prostate-cancer-patients-58543https://curecurrent.com/trials/study-of-tasquinimod-in-asian-chemo-na-ve-patients-with-metastatic-castrate-resistant-prostate-cancer-58544https://curecurrent.com/trials/urology-san-antonio-mri-microus-comparison-58545https://curecurrent.com/trials/home-based-exercise-intervention-for-patients-with-metastatic-prostate-cancer-58546https://curecurrent.com/trials/lipitor-and-biguanide-to-androgen-delay-trial-58547https://curecurrent.com/trials/a-trial-assessing-post-operative-use-of-prospare-a-rectal-obturator-in-prostate-cancer-radiotherapy-58548https://curecurrent.com/trials/observation-of-outcomes-and-side-effects-of-cesium-131-in-combination-with-external-beam-radiation-for-the-treatment-of-58549https://curecurrent.com/trials/detection-rate-of-prostate-cancer-in-men-undergoing-mri-58550https://curecurrent.com/trials/sexual-health-and-rehabilitation-eclinic-shareclinic-58551https://curecurrent.com/trials/an-exercise-trial-and-economic-analysis-in-men-with-prostate-cancer-58552https://curecurrent.com/trials/the-effect-of-adt-on-psma-expression-in-metastatic-prostate-cancer-58553https://curecurrent.com/trials/adt-exercise-trial-and-economic-analysis-58554https://curecurrent.com/trials/early-prostate-cancer-predicting-treatment-response-58555https://curecurrent.com/trials/docetaxel-prednisone-versus-docetaxel-prednisone-and-enzalutamide-in-castration-resistant-prostate-cancer-58556https://curecurrent.com/trials/the-effects-of-coenzyme-a-combined-with-abiraterone-on-patients-with-crpc-58557https://curecurrent.com/trials/pk-pd-tolerability-and-safety-of-mdpk67b-in-healthy-volunteers-58558https://curecurrent.com/trials/verification-of-shear-wave-elastography-for-detection-of-prostate-cancer-58559https://curecurrent.com/trials/cytoreductive-prostatectomy-in-treating-patients-with-newly-diagnosed-metastatic-prostate-cancer-58560https://curecurrent.com/trials/erythropoietin-to-enhance-recovery-of-erectile-function-in-men-following-radical-prostatectomy-58561https://curecurrent.com/trials/zk-epo-given-with-prednisone-in-patients-with-metastatic-androgen-independent-prostate-cancer-58562https://curecurrent.com/trials/collecting-and-storing-blood-and-tumor-tissue-samples-from-patients-undergoing-prostatectomy-or-transurethral-resection-58563https://curecurrent.com/trials/role-of-piwi-protein-interacting-rna-mirna-194-and-amino-acids-in-patients-with-prostate-cancer-58564https://curecurrent.com/trials/phase-iii-study-of-dcvac-pca-added-to-standard-chemotherapy-for-men-with-metastatic-castration-resistant-prostate-cancer-58565https://curecurrent.com/trials/phase-ii-high-risk-prostate-cancer-trial-using-gene-androgen-deprivation-therapies-radiotherapy-surgery-58566https://curecurrent.com/trials/micro-wave-ablation-under-organ-based-tracking-in-patients-with-prostate-cancer-fostine-58567https://curecurrent.com/trials/ketogenic-diet-and-prostate-cancer-surveillance-pilot-58568https://curecurrent.com/trials/cell-free-dna-and-rna-in-blood-frommetastatic-prostate-cancer-patients-58569https://curecurrent.com/trials/effects-of-two-doses-of-mpx-capsules-on-rising-prostate-specific-antigen-levels-in-men-following-initial-therapy-for-pro-58570https://curecurrent.com/trials/outcome-assessment-of-an-active-surveillance-program-for-low-risk-prostate-cancer-an-observational-study-58571https://curecurrent.com/trials/telaglenastat-talazoparib-in-prostate-cancer-58572https://curecurrent.com/trials/micro-ultrasound-magnetic-resonance-imaging-001-58573https://curecurrent.com/trials/detection-of-clinically-significant-prostate-cancer-using-a-urinary-multimarker-sensor-58574https://curecurrent.com/trials/axumin-petmri-imaging-following-focal-cryo-ablation-fca-58575https://curecurrent.com/trials/investigating-the-effects-of-mikei-red-reishi-essence-ex-on-the-immune-system-of-prostate-cancer-patients-and-patients-w-58576https://curecurrent.com/trials/sipuleucel-t-and-low-protein-diet-in-patients-with-metastatic-castrate-resistant-prostate-cancer-58577https://curecurrent.com/trials/a-pilot-trial-using-br55-ultrasound-contrast-agent-in-the-assessment-of-prostate-cancer-58578https://curecurrent.com/trials/does-protein-restriction-inhibit-prostrate-cancer-growth-58579https://curecurrent.com/trials/adjuvant-treatment-of-prostate-cancer-with-docetaxel-or-not-after-radical-radiotherapy-58580https://curecurrent.com/trials/docetaxel-prednisone-and-pasireotide-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-58581https://curecurrent.com/trials/study-of-the-effect-of-gtx-758-on-serum-psa-and-testosterone-in-men-with-prostate-cancer-58582https://curecurrent.com/trials/lutetium-177-lu177-prostate-specific-antigen-psma-directed-endoradiotherapy-58583https://curecurrent.com/trials/pantoprazole-and-docetaxel-for-men-with-metastatic-castration-resistant-prostate-cancer-58584https://curecurrent.com/trials/study-of-erectile-dysfunction-urinary-incontinence-and-related-qol-after-tookad-vtp-for-low-risk-prostate-cancer-58585https://curecurrent.com/trials/european-randomised-study-of-tookad-soluble-for-prostate-cancer-vs-active-surveillance-post-study-follow-up-58586https://curecurrent.com/trials/radioimmunotherapy-in-prostate-cancer-using-177lu-j591-antibody-58587https://curecurrent.com/trials/spaceoar-system-pivotal-study-58588https://curecurrent.com/trials/bioavailability-study-of-odm-201-in-subjects-with-metastatic-chemotherapy-naive-castration-resistant-prostate-cancer-58589https://curecurrent.com/trials/to-compare-the-safety-and-pharmacokinetics-of-pt105-with-pt105r-in-healthy-postmenopausal-female-volunteers-58590https://curecurrent.com/trials/augmented-bladder-neck-reconstruction-trial-for-improved-urinary-function-after-radical-prostatectomy-58591https://curecurrent.com/trials/prostate-cancer-secondary-screening-in-sapienza-and-policlinico-umberto-i-58592https://curecurrent.com/trials/stellate-ganglion-block-for-hot-flushes-in-men-treated-with-adt-58593https://curecurrent.com/trials/learning-mri-and-histology-image-mappings-for-cancer-diagnosis-and-prognosis-58594https://curecurrent.com/trials/a-phase-i-ii-study-on-stereotactic-body-radiotherapy-in-3-fractions-for-low-int-risk-prostate-cancer-58595https://curecurrent.com/trials/rucaparib-and-nivolumab-in-patients-with-prostate-or-endometrial-cancer-58596https://curecurrent.com/trials/multimedia-based-hormonal-therapy-information-program-for-patients-with-prostate-cancer-58597https://curecurrent.com/trials/pd-l1-inhibition-as-checkpoint-immunotherapy-for-neuroendocrine-phenotype-prostate-cancer-58598https://curecurrent.com/trials/mri-us-fusion-imaging-and-biopsy-in-combination-with-nanoparticle-directed-focal-therapy-for-ablation-of-prostate-tissue-58599https://curecurrent.com/trials/a-study-of-shr3680-in-treating-patients-with-hormone-sensitive-prostate-cancer-58600https://curecurrent.com/trials/the-prognosis-of-lipid-reprogramming-with-rosuvastatin-in-castrated-egyptian-prostate-cancer-patients-58601https://curecurrent.com/trials/prostate-cancer-in-firemen-early-diagnosis-because-of-increased-diagnostic-pressure-58602https://curecurrent.com/trials/expanded-access-68gallium-psma-11-pet-for-prostate-cancer-58603https://curecurrent.com/trials/the-immunodynamic-effect-of-radiotherapy-in-prostate-cancer-patients-58604https://curecurrent.com/trials/prostatic-hyperplasia-treatment-and-cancer-prevention-58605https://curecurrent.com/trials/intensity-modulated-radiation-therapy-with-or-without-decreased-radiation-dose-to-erectile-tissue-in-treating-patients-w-58606https://curecurrent.com/trials/kv-cbct-and-ultrasound-imaging-in-guiding-radiation-therapy-in-patients-with-prostate-liver-or-pancreatic-cancer-58607https://curecurrent.com/trials/hormone-therapy-and-docetaxel-or-hormone-therapy-alone-in-treating-patients-with-metastatic-prostate-cancer-58608https://curecurrent.com/trials/comparison-of-radiation-therapy-regimens-in-treating-patients-with-localized-prostate-cancer-58609https://curecurrent.com/trials/high-resolution-pet-mri-before-prostate-cancer-hifu-58610https://curecurrent.com/trials/triptorelin-flutamide-and-external-beam-radiation-therapy-or-external-beam-radiation-therapy-alone-in-treating-patients-58611https://curecurrent.com/trials/a-study-of-shr3680-in-combination-with-docetaxel-in-the-treatment-of-mcrpc-58612https://curecurrent.com/trials/nerve-grafting-with-an-allograft-during-radical-prostatectomy-extended-follow-up-in-a-prospective-randomized-trial-58613https://curecurrent.com/trials/beta-adrenergic-receptor-blockade-as-a-novel-therapy-for-patients-with-adenocarcinoma-of-the-prostate-58614https://curecurrent.com/trials/study-of-blood-and-urine-samples-in-patients-with-newly-diagnosed-localized-prostate-cancer-treated-with-hormone-therapy-58615https://curecurrent.com/trials/dovitinib-tki258-in-patients-with-castration-resistant-prostate-cancer-58616https://curecurrent.com/trials/ldr-brachytherapy-versus-sbrt-for-low-and-intermediate-risk-prostate-cancer-patients-58617https://curecurrent.com/trials/staying-strong-and-healthy-during-androgen-deprivation-therapy-adt-for-men-58618https://curecurrent.com/trials/new-biopsy-needle-evaluation-of-prostate-biopsy-quality-58619https://curecurrent.com/trials/evaluation-of-four-treatment-modalities-in-prostate-cancer-with-low-or-early-intermediate-risk-58620https://curecurrent.com/trials/hdr-brachytherapy-vs-ldr-brachytherapy-monotherapy-in-localized-prostate-cancer-58621https://curecurrent.com/trials/implementing-routine-molecular-characterization-in-patients-with-metastatic-castration-resistant-prostate-cancer-by-ngs-58622https://curecurrent.com/trials/prostate-cancer-screening-in-men-with-germline-brca2-mutations-58623https://curecurrent.com/trials/neoadjuvant-therapy-of-abiraterone-plus-adt-for-intraductal-carcinoma-of-the-prostate-58624https://curecurrent.com/trials/staging-prostate-cancer-with-hybrid-c11-choline-pet-mr-and-mpmri-58625https://curecurrent.com/trials/oral-calcitriol-with-ketoconazole-in-crpc-58626https://curecurrent.com/trials/a-study-of-shr2554-alone-or-in-combination-with-shr3680-in-the-treatment-of-mcrpc-58627https://curecurrent.com/trials/surgical-and-functional-outcomes-of-rectourethral-fistulas-surgery-with-gracilis-flap-interposition-after-localized-pros-58628https://curecurrent.com/trials/a-phase-i-study-of-a-dna-vaccine-encoding-androgen-receptor-ligand-binding-domain-ar-lbd-gmcsf-58629https://curecurrent.com/trials/sexual-and-urological-rehabilitation-to-men-operated-for-prostate-cancer-and-their-partners-58630https://curecurrent.com/trials/a-prospective-study-on-18f-dcfpyl-pet-ct-imaging-in-biochemical-recurrence-of-prostate-cancer-58631https://curecurrent.com/trials/a-phase-i-ii-safety-clinical-trial-of-dcvac-pca-and-oncos-102-in-men-with-metastatic-castration-resistant-prostate-cance-58632https://curecurrent.com/trials/a-study-for-patients-with-prostate-cancer-to-see-whether-delivering-an-extra-dose-of-radiation-to-parts-of-the-body-with-58633https://curecurrent.com/trials/18f-psma-pet-ct-for-visualization-of-glioblastoma-multiforme-58634https://curecurrent.com/trials/dynamic-whole-body-positron-emission-tomography-computed-tomography-imaging-58635https://curecurrent.com/trials/prostatic-artery-embolization-in-advanced-prostate-cancer-58636https://curecurrent.com/trials/internal-carotid-artery-blood-flow-in-robot-assisted-laparoscopic-prostatectomy-58637https://curecurrent.com/trials/modeling-clinical-failure-in-prostate-cancer-patients-based-on-a-two-stage-statistical-model-58638https://curecurrent.com/trials/cabazitaxel-and-prednisone-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-58639https://curecurrent.com/trials/validation-of-facbc-for-detection-of-metastasis-among-high-risk-prostate-cancer-patients-with-presumed-localized-disease-58640https://curecurrent.com/trials/a-phase-iii-intensity-radiotherapy-dose-escalation-for-prostate-cancer-using-hypofractionation-58641https://curecurrent.com/trials/18f-psma-11-pet-ct-phase-3-clinical-study-58642https://curecurrent.com/trials/radiation-hormone-and-docetaxel-vs-radiation-hormone-in-patients-with-high-risk-localized-prostate-cancer-58643https://curecurrent.com/trials/study-of-sxl01-in-patients-with-metastatic-castration-resistant-prostate-cancer-prostirna-58644https://curecurrent.com/trials/androgen-deprivation-therapy-and-apalutamide-with-or-without-radiation-therapy-for-the-treatment-of-biochemically-recurr-58645https://curecurrent.com/trials/phase-ii-pap-plus-gm-csf-versus-gm-csf-alone-for-non-metastatic-prostate-cancer-58646https://curecurrent.com/trials/salvage-hypofractionated-accelerated-versus-standard-radiotherapy-for-biochemical-failure-after-prostatectomy-58647https://curecurrent.com/trials/investigating-bone-and-skeletal-muscle-interaction-in-men-with-prostate-cancer-58648https://curecurrent.com/trials/neoadjuvant-bkm120-in-high-risk-prostate-cancer-58649https://curecurrent.com/trials/prostatectomies-using-einstein-vision-3d-58650https://curecurrent.com/trials/evaluating-the-role-of-both-psma-and-64cu-pet-ct-total-body-in-patients-with-locally-relapsed-prostate-cancer-58651https://curecurrent.com/trials/pharmacokinetic-food-effect-study-of-abiraterone-acetate-aa-in-castration-resistant-prostate-cancer-58652https://curecurrent.com/trials/consensus-method-to-evaluate-the-conformity-of-prescription-of-a-chemotherapy-58653https://curecurrent.com/trials/a-prospective-single-centre-single-blinded-study-of-proud-for-prostate-carcinoma-diagnosis-58654https://curecurrent.com/trials/utilising-ctc-counts-to-optimize-systemic-therapy-of-metastatic-prostate-cancer-58655https://curecurrent.com/trials/docetaxel-plus-lycopene-in-castration-resistant-chemotherapy-na-ve-prostate-cancer-patients-58656https://curecurrent.com/trials/phase-ii-study-of-the-use-of-neoadjuvant-cabazitaxel-with-hormonal-treatment-in-patients-operable-prostate-cancer-assess-58657https://curecurrent.com/trials/mri-guided-stereotactic-body-radiotherapy-sbrt-with-simultaneous-integrated-boost-for-prostate-cancer-58658https://curecurrent.com/trials/prostate-biopsies-with-target-lesion-on-mri-58659https://curecurrent.com/trials/green-tea-black-tea-or-water-in-treating-patients-with-prostate-cancer-undergoing-surgery-58660https://curecurrent.com/trials/study-of-trc105-with-abiraterone-and-with-enzalutamide-in-prostate-cancer-patients-progressing-on-therapy-58661https://curecurrent.com/trials/clinical-evaluation-of-the-exodx-prostate-intelliscore-epi-58662https://curecurrent.com/trials/exploring-the-mechanisms-and-dynamics-of-clonal-evolution-leading-to-recurrence-in-prostate-cancer-58663https://curecurrent.com/trials/men-with-metastatic-castrate-resistant-prostate-cancer-treated-with-either-sipuleucel-t-provenge-abiraterone-acetate-zyt-58664https://curecurrent.com/trials/timing-of-hdr-with-ebrt-in-localised-prostate-cancer-toxicity-and-quality-of-life-assessment-58665https://curecurrent.com/trials/evaluation-of-gallium-68-hbed-cc-psma-imaging-in-prostate-cancer-patients-58666https://curecurrent.com/trials/phase-1-study-to-evaluate-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-pasireotide-lar-in-patients-w-58667https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-a-liproca-depot-injection-in-patients-with-prostate-cancer-58668https://curecurrent.com/trials/ability-of-cardio-q-for-prediction-of-hypotension-58669https://curecurrent.com/trials/a-dose-finding-study-with-i-v-panobinostat-lbh589-docetaxel-and-prednisone-in-patients-with-hormone-refractory-prostate-58670https://curecurrent.com/trials/a-phase-i-ii-open-label-study-of-mcs110-in-patients-with-prostate-cancer-and-bone-metastases-58671https://curecurrent.com/trials/safety-of-lbh589-alone-and-in-combination-with-iv-docetaxel-and-prednisone-58672https://curecurrent.com/trials/pelvic-health-and-physical-therapy-to-improve-lives-of-prostate-cancer-patients-undergoing-prostatectomy-58673https://curecurrent.com/trials/efficacy-and-safety-of-patupilone-in-men-18-years-with-metastatic-hormone-refractory-prostate-cancer-58674https://curecurrent.com/trials/hypofractionated-accelerated-radiotherapy-for-low-risk-localized-prostate-cancer-58675https://curecurrent.com/trials/prostate-cancer-in-renal-transplants-recipients-58676https://curecurrent.com/trials/prospective-prostate-biomarker-study-58677https://curecurrent.com/trials/multi-center-randomized-clinical-trial-irreversible-electroporation-for-the-ablation-of-localized-prostate-cancer-58678https://curecurrent.com/trials/registry-of-irreversible-electroporation-for-the-ablation-of-prostate-cancer-with-use-of-nanoknife-device-58679https://curecurrent.com/trials/drug-drug-interaction-of-shr3680-with-repaglinide-and-bupropion-58680https://curecurrent.com/trials/ct-validation-of-ultrasound-based-planning-for-high-dose-rate-hdr-prostate-brachytherapy-using-vitesse-58681https://curecurrent.com/trials/gallium-68-psma-11-pet-in-intermediate-to-high-risk-preprostatectomy-patients-58682https://curecurrent.com/trials/abiraterone-race-in-metastatic-castrate-resistant-prostate-cancer-58683https://curecurrent.com/trials/a-study-of-immediate-9-months-adjuvant-hormone-therapy-with-triptorelin-11-25-mg-versus-active-surveillance-after-radica-58684https://curecurrent.com/trials/phase-ib-of-abiraterone-acetate-plus-bez235-or-bkm120-in-castration-resistant-prostate-cancer-crpc-patients-58685https://curecurrent.com/trials/zolendronate-for-the-prevention-of-bone-loss-in-men-w-prostate-ca-on-long-term-androgen-deprivation-58686https://curecurrent.com/trials/study-to-evaluate-ctdna-of-mcspc-patients-receiving-apalutamide-in-japan-58687https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gs-5829-alobresib-as-a-single-agent-and-in-combination-with-58688https://curecurrent.com/trials/pet-mri-study-of-men-with-highly-suspicious-mri-lesions-that-showed-no-clinically-significant-prostate-cancer-following-58689https://curecurrent.com/trials/improving-bio-availability-of-the-expensive-oral-oncolytic-drug-abiraterone-by-food-intake-58690https://curecurrent.com/trials/pharmacogenetic-study-in-castration-resistant-prostate-cancer-patients-treated-with-abiraterone-acetate-58691https://curecurrent.com/trials/impact-of-monosodium-glutamate-on-68ga-psma-11-pet-imaging-biodistribution-in-patients-with-prostate-cancer-58692https://curecurrent.com/trials/carboplatin-everolimus-and-prednisone-in-treating-patients-with-metastatic-prostate-cancer-that-progressed-after-docetax-58693https://curecurrent.com/trials/feasibility-trial-in-men-with-hormone-sensitive-oligometastatic-prostate-cancer-58694https://curecurrent.com/trials/evaluation-of-a-web-based-decision-aid-tool-for-prostate-cancer-patients-58695https://curecurrent.com/trials/prostate-adenocarcinoma-transcutaneous-hormones-58696https://curecurrent.com/trials/hypo-fractionated-stereotactic-body-radiotherapy-for-localized-prostate-cancer-58697https://curecurrent.com/trials/phase-2-trial-of-enzastaurin-in-prostate-cancer-in-participants-who-have-had-hormonal-and-chemotherapy-58698https://curecurrent.com/trials/5-fractions-of-pelvic-sabr-with-intra-prostatic-sabr-58699https://curecurrent.com/trials/safety-and-efficacy-study-of-hypofractionated-radiotherapy-and-androgen-deprivation-therapy-for-prostate-cancer-58700https://curecurrent.com/trials/a-study-of-aplidin-plitidepsin-in-subjects-with-advanced-prostate-cancer-58701https://curecurrent.com/trials/effects-of-6-week-reduced-exertion-high-intensity-interval-training-protocol-in-patients-with-prostate-cancer-58702https://curecurrent.com/trials/sabr-including-regional-lymph-node-irradiation-for-patients-with-high-risk-prostate-cancer-saturn-58703https://curecurrent.com/trials/two-stereotactic-ablative-adaptive-radiotherapy-treatments-for-localized-prostate-cancer-58704https://curecurrent.com/trials/upar-pet-mri-in-patients-with-prostate-cancer-for-evaluation-of-tumor-aggressiveness-58705https://curecurrent.com/trials/mild-cognitive-impairment-in-men-following-androgen-deprivation-58706https://curecurrent.com/trials/clinical-trials-of-adjuvant-androgen-deprivation-in-localized-prostate-cancer-58707https://curecurrent.com/trials/11c-and-18f-choline-pet-mr-imaging-for-prostate-cancer-58708https://curecurrent.com/trials/efficacy-of-rotations-between-abiraterone-acetate-and-apalutamide-in-mcrpc-patients-58709https://curecurrent.com/trials/accumulation-of-dietary-bioactives-and-prostate-cancer-58710https://curecurrent.com/trials/evaluation-of-the-sensei-laparoscopic-tethered-gamma-probe-for-99mtc-nanocolloid-sentinel-lymph-node-biopsy-in-prostate-58711https://curecurrent.com/trials/68ga-psma-r2-in-patients-with-biochemical-relapse-br-and-metastatic-prostate-cancer-mpca-58712https://curecurrent.com/trials/rhenium-188-hedp-vs-radium-223-chloride-in-patients-with-advanced-prostate-cancer-refractory-to-hormonal-therapy-58713https://curecurrent.com/trials/abiraterone-acetate-in-combination-with-docetaxel-after-disease-progression-to-abiraterone-acetate-in-metastatic-castrat-58714https://curecurrent.com/trials/molecular-mechanisms-underlying-prostate-cancer-disparities-58715https://curecurrent.com/trials/evaluation-of-efficacy-of-tookad-vtp-versus-active-surveillance-for-intermediate-risk-localized-prostate-cancer-58716https://curecurrent.com/trials/abiraterone-acetate-and-prednisone-with-or-without-veliparib-in-treating-patients-with-metastatic-castration-resistant-p-58717https://curecurrent.com/trials/focal-radiation-therapy-for-the-treatment-of-low-or-intermediate-risk-prostate-cancer-58718https://curecurrent.com/trials/a-phase-2-study-with-enzastaurin-plus-chemotherapy-or-placebo-plus-chemotherapy-for-prostate-cancer-patients-58719https://curecurrent.com/trials/testosterone-revival-abolishes-negative-symptoms-fosters-objective-response-and-modulates-enzalutamide-resistance-58720https://curecurrent.com/trials/a-registry-for-hereditary-cancer-risk-assessment-and-genetic-testing-58721https://curecurrent.com/trials/high-intensity-training-for-men-with-prostate-cancer-on-active-surveillance-a-feasibility-study-58722https://curecurrent.com/trials/18f-naf-pet-mr-vs-99mtc-mdp-spect-ct-to-detect-bone-metastases-in-prostate-cancer-patients-58723https://curecurrent.com/trials/a-study-evaluating-tolerability-pharmacokinetics-and-preliminary-efficacy-of-hc-1119-in-patients-58724https://curecurrent.com/trials/dendritic-cell-dc-based-vaccines-loaded-with-allogeneic-prostate-cell-lines-in-combination-with-androgen-ablation-in-pat-58725https://curecurrent.com/trials/a-study-evaluating-enzalutamide-pharmacokinetics-and-pharmacodynamics-and-related-changes-after-drug-switch-58726https://curecurrent.com/trials/radium-ra-223-with-enzalutamide-compared-to-enzalutamide-alone-in-men-with-metastatic-castration-refractory-prostate-can-58727https://curecurrent.com/trials/ccro044-quality-of-life-assessments-associated-with-a-physician-communication-intervention-for-prostate-cancer-patients-58728https://curecurrent.com/trials/prostate-cancer-stereotactic-radiotherapy-58729https://curecurrent.com/trials/decision-navigation-for-advanced-prostate-cancer-treatment-options-using-mhealth-58730https://curecurrent.com/trials/focal-high-intensity-focused-ultrasound-for-primary-localized-prostate-cancer-midterm-oncological-outcomes-58731https://curecurrent.com/trials/dosimetry-and-safety-phase-1-study-with-68ga-psma-11-sterile-cold-kit-58732https://curecurrent.com/trials/integrated-boost-to-the-dominant-intraprostatic-nodule-based-on-ga-68-psma-pet-mr-study-of-sbrt-with-prostate-cancer-58733https://curecurrent.com/trials/green-tea-extract-in-treating-patients-with-low-risk-prostate-cancer-58734https://curecurrent.com/trials/multi-academic-center-study-of-xofigo-patients-58735https://curecurrent.com/trials/adjuvant-radiation-therapy-plus-hormone-therapy-compared-with-radiation-therapy-alone-in-treating-patients-with-stage-ii-58736https://curecurrent.com/trials/hormone-therapy-plus-chemotherapy-in-treating-patients-with-prostate-cancer-58737https://curecurrent.com/trials/a-pilot-study-of-the-feasibility-of-chronic-cavernous-nerve-stimulation-to-promote-regeneration-and-erectile-function-58738https://curecurrent.com/trials/hormone-therapy-plus-radiation-therapy-with-or-without-combination-chemotherapy-in-treating-patients-with-prostate-cance-58739https://curecurrent.com/trials/dose-finding-study-of-gsk2636771-when-administered-in-combination-with-enzalutamide-in-male-subjects-with-metastatic-cas-58740https://curecurrent.com/trials/external-beam-radiation-therapy-plus-implanted-radiation-therapy-in-treating-patients-with-prostate-cancer-58741https://curecurrent.com/trials/economic-evaluation-of-robot-assisted-laparoscopic-radical-prostatectomy-vs-conventional-laparoscopic-radical-prostatect-58742https://curecurrent.com/trials/rovalpituzumab-tesirine-in-delta-like-protein-3-expressing-advanced-solid-tumors-58743https://curecurrent.com/trials/phase-i-trial-of-pace-for-metastatic-prostate-cancer-58744https://curecurrent.com/trials/trovax-in-subjects-with-hormone-refractory-prostate-cancer-hrpc-58745https://curecurrent.com/trials/personalizing-enzalutamide-therapy-by-understanding-the-relation-between-tumor-mrnas-mirnas-and-treatment-response-58746https://curecurrent.com/trials/ct-2584-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-previous-therapy-58747https://curecurrent.com/trials/ipilimumab-in-combination-with-androgen-suppression-therapy-in-treating-patients-with-metastatic-hormone-resistant-prost-58748https://curecurrent.com/trials/psma-imaging-of-localized-prostate-cancer-58749https://curecurrent.com/trials/clinical-trial-of-selegiline-plus-docetaxel-for-the-treatment-of-metastatic-castrate-resistant-prostate-adenocarcinoma-58750https://curecurrent.com/trials/gallium-ga-68-labeled-psma-11-pet-ct-and-fluciclovine-f18-pet-ct-in-imaging-participants-with-recurrent-prostate-cancer-58751https://curecurrent.com/trials/validation-of-digital-morphometry-for-cancer-risk-in-benign-prostate-biopsies-58752https://curecurrent.com/trials/enzalutamide-and-hormone-therapy-before-during-and-after-radiation-for-high-risk-localized-prostate-cancer-58753https://curecurrent.com/trials/trial-to-compare-urinary-continence-recovery-after-robotic-radical-prostatectomy-with-or-without-rhabdosphincter-reconst-58754https://curecurrent.com/trials/exercising-together-during-radiation-treatment-58755https://curecurrent.com/trials/impact-of-anticoagulants-and-antiplatelets-in-patients-on-transurethral-resection-of-the-prostate-58756https://curecurrent.com/trials/clinical-outcomes-in-men-with-prostate-cancer-who-selected-active-surveillance-using-prolaris-testing-58757https://curecurrent.com/trials/plx3397-radiation-therapy-and-antihormone-therapy-in-treating-patients-with-intermediate-or-high-risk-prostate-cancer-58758https://curecurrent.com/trials/the-ability-of-adipose-flap-over-the-nvb-to-improve-sexual-and-urinary-function-following-radical-prostatectomy-58759https://curecurrent.com/trials/neoadjuvant-j591-treatment-for-prostate-cancer-58760https://curecurrent.com/trials/effectiveness-of-68ga-psma-pet-mri-for-improving-the-detection-of-cspca-in-lesions-with-pi-rads-score-3-58761https://curecurrent.com/trials/engaging-newly-diagnosed-men-about-cancer-treatment-options-58762https://curecurrent.com/trials/evaluation-of-cardiotoxicity-and-hypertension-in-patients-with-non-metastatic-castration-resistant-prostatic-carcinoma-58763https://curecurrent.com/trials/molecular-features-and-pathways-in-predicting-drug-resistance-in-patients-with-metastatic-castration-resistant-prostate-58764https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-prostate-cancer-58765https://curecurrent.com/trials/enhancing-survivorship-care-planning-for-patients-with-localized-prostate-cancer-using-a-couple-focused-web-based-tailor-58766https://curecurrent.com/trials/early-dvc-ligation-and-urinary-continence-recovery-after-rarp-58767https://curecurrent.com/trials/a-registry-of-participants-with-prostate-cancer-in-asia-58768https://curecurrent.com/trials/olaparib-before-surgery-in-treating-participants-with-localized-prostate-cancer-58769https://curecurrent.com/trials/focal-laser-ablation-of-prostate-tissue-58770https://curecurrent.com/trials/prostate-volume-changes-following-prostate-brachytherapy-with-iodine-125-seeds-58771https://curecurrent.com/trials/acupuncture-treatment-for-hot-flashes-study-58772https://curecurrent.com/trials/evaluation-of-diagnostic-accuracy-of-68ga-ga-psma-11-pet-ct-in-primary-staging-of-intermediate-and-high-risk-prostatic-c-58773https://curecurrent.com/trials/fluorine-f-18-sodium-fluoride-pet-ct-and-whole-body-and-axial-mri-in-finding-metastases-in-patients-with-recurrent-prost-58774https://curecurrent.com/trials/contrast-enhanced-mri-of-the-prostate-58775https://curecurrent.com/trials/effects-of-a-new-diagnostic-test-on-the-care-of-prostate-cancer-patients-the-promark-clinical-utility-study-58776https://curecurrent.com/trials/a-phase-ii-study-of-androgen-deprivation-therapy-with-or-without-palbociclib-in-rb-positive-metastatic-prostate-cancer-58777https://curecurrent.com/trials/enzalutamide-in-combination-with-psa-tricom-in-patients-with-non-metastatic-castration-sensitive-prostate-cancer-58778https://curecurrent.com/trials/active-surveillance-for-low-risk-prostate-cancer-evaluation-of-the-efficacy-of-minimally-invasive-active-surveillance-58779https://curecurrent.com/trials/armor1-study-of-tok-001-to-treat-castration-resistant-prostate-cancer-58780https://curecurrent.com/trials/use-of-recombinant-adenovirus-therapy-to-treat-localized-prostate-cancer-58781https://curecurrent.com/trials/prostate-cancer-detection-rates-of-standard-transrectal-prostate-biopsy-and-mr-guided-fusion-transrectal-prostate-biopsy-58782https://curecurrent.com/trials/improving-outcomes-in-cancer-patients-on-oral-anti-cancer-medications-using-a-multi-modal-mobile-health-intervention-58783https://curecurrent.com/trials/carboplatin-plus-docetaxel-taxotere-in-anaplastic-prostate-cancer-58784https://curecurrent.com/trials/paclitaxel-and-carboplatin-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therap-58785https://curecurrent.com/trials/effect-of-ramosetron-on-heart-rate-corrected-qt-interval-during-robot-assisted-laparoscopic-prostatectomy-with-steep-tre-58786https://curecurrent.com/trials/hdr-brachytherapy-plus-stereotactic-ablative-prostate-radiotherapy-for-patients-with-intermediate-and-high-risk-prostate-58787https://curecurrent.com/trials/radiation-therapy-and-ixabepilone-in-treating-patients-with-high-risk-stage-iii-prostate-cancer-after-surgery-58788https://curecurrent.com/trials/circulating-tumor-cells-in-prostate-cancer-patients-58789https://curecurrent.com/trials/towards-optimal-prescription-of-chemotherapy-in-prostate-cancer-58790https://curecurrent.com/trials/68ga-psma-pet-ct-scan-for-diagnosis-and-management-of-prostate-cancer-58791https://curecurrent.com/trials/evaluation-of-tolerance-and-efficacy-retrospective-data-of-xofigo-58792https://curecurrent.com/trials/a-phase-ii-study-of-increased-dose-abiraterone-acetate-in-patients-with-castration-resistant-prostate-cancer-58793https://curecurrent.com/trials/apalutamide-with-radiotherapy-and-androgen-deprivation-therapy-in-prostate-cancer-58794https://curecurrent.com/trials/an-epidemiological-study-of-genetic-risk-factors-for-prostate-cancer-in-african-american-and-caucasian-males-58795https://curecurrent.com/trials/comparison-of-multi-parametric-and-bi-parametric-magnetic-resonance-imaging-in-men-with-suspicion-of-prostate-cancer-58796https://curecurrent.com/trials/interval-intense-exercise-trial-for-men-with-metastatic-castrate-resistant-prostate-cancer-58797https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-ii-or-stage-iii-prostate-cancer-58798https://curecurrent.com/trials/investigating-and-characterizing-the-immune-response-to-prostate-cancer-58799https://curecurrent.com/trials/sequencing-abiraterone-and-enzalutamide-in-mcrpc-58800https://curecurrent.com/trials/treatment-preference-and-patient-centered-prostate-cancer-care-58801https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-prostate-cancer-58802https://curecurrent.com/trials/docetaxel-and-erlotinib-in-treating-older-patients-with-prostate-cancer-58803https://curecurrent.com/trials/ipilimumab-and-sargramostim-in-treating-patients-with-metastatic-prostate-cancer-58804https://curecurrent.com/trials/internet-based-exercise-and-diet-support-in-prostate-cancer-survivors-58805https://curecurrent.com/trials/evaluation-of-post-operative-biochemical-recurrence-in-patients-submitted-to-radical-prostatectomy-under-general-opioid-58806https://curecurrent.com/trials/multicentric-evaluation-of-the-true-negative-predictive-value-of-multiparametric-mri-for-the-detection-of-prostate-cance-58807https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-for-localized-prostate-cancer-58808https://curecurrent.com/trials/post-discharge-opioid-reduction-intervention-for-open-laparoscopic-and-endoscopic-surgery-58809https://curecurrent.com/trials/efficacy-and-safety-assessment-of-ire-of-localized-prostate-cancer-58810https://curecurrent.com/trials/internal-radiation-therapy-in-treating-patients-with-low-risk-prostate-cancer-58811https://curecurrent.com/trials/use-of-laser-interstitial-thermal-therapy-in-the-focal-treatment-of-localized-prostate-cancer-58812https://curecurrent.com/trials/sc10914-monotherapy-for-the-mcrpc-with-g-s-brca-mutation-58813https://curecurrent.com/trials/ga-68-psma-11-in-high-risk-prostate-cancer-58814https://curecurrent.com/trials/phase-i-study-to-evaluate124i-a11-psca-minibody-in-patients-with-metastatic-prostate-bladder-and-pancreatic-cancer-58815https://curecurrent.com/trials/low-residue-diet-in-treating-diarrhea-in-patients-receiving-pelvic-radiation-therapy-58816https://curecurrent.com/trials/prospective-assessment-of-image-registration-for-the-diagnosis-of-prostate-cancer-58817https://curecurrent.com/trials/treating-patients-with-prostate-cancer-that-did-not-respond-to-hormone-therapy-58818https://curecurrent.com/trials/c11-sodium-acetate-pet-ct-imaging-of-pca-58819https://curecurrent.com/trials/magnetic-resonance-mr-imaging-with-hyperpolarized-pyruvate-hp-13c-in-castration-resistant-prostate-cancer-58820https://curecurrent.com/trials/targeted-biopsies-in-determining-response-in-patients-with-prostate-cancer-undergoing-high-dose-rate-brachytherapy-58821https://curecurrent.com/trials/rpcrc-validation-study-58822https://curecurrent.com/trials/supportive-therapy-in-androgen-deprivation-clinic-in-improving-health-outcomes-and-managing-side-effects-in-patients-wit-58823https://curecurrent.com/trials/decision-support-tools-for-men-with-prostate-cancer-clinical-lifestyle-model-58824https://curecurrent.com/trials/multicenter-study-of-hypofractionated-postoperative-radiotherapy-in-patients-diagnosed-with-prostate-carcinoma-58825https://curecurrent.com/trials/multicentre-international-study-for-the-prevention-with-ialuril-of-radio-induced-cystitis-mistic-58826https://curecurrent.com/trials/visually-enhanced-education-about-prostate-cancer-58827https://curecurrent.com/trials/image-guided-biopsies-in-identifying-mechanisms-of-resistance-in-participants-with-metastatic-castration-resistant-prost-58828https://curecurrent.com/trials/molecular-stratification-profiling-protocol-in-metastatic-castration-resistant-prostate-cancer-mcrpc-maestro-58829https://curecurrent.com/trials/extension-of-solumatrix-tm-abiraterone-acetate-in-patients-who-completed-study-number-chl-aa-201-58830https://curecurrent.com/trials/technetium-based-radioguided-surgery-for-prostate-cancer-trace-study-58831https://curecurrent.com/trials/trial-of-pembrolizumab-in-metastatic-castration-resistant-prostate-cancer-58832https://curecurrent.com/trials/a-phase-ii-randomised-trial-of-three-regimens-of-gx301-vaccination-in-castration-resistant-prostate-cancer-58833https://curecurrent.com/trials/peripheral-vs-selective-tumor-marker-venous-sampling-in-prostate-cancer-58834https://curecurrent.com/trials/a-phase-1-trial-of-shr3680-with-or-without-shr3162-in-prostate-cancer-58835https://curecurrent.com/trials/a-safety-and-pharmacokinetics-study-of-niraparib-plus-an-androgen-receptor-targeted-therapy-in-men-with-metastatic-castr-58836https://curecurrent.com/trials/psma-pet-imaging-in-patients-with-metastatic-prostate-cancer-institutional-evaluation-of-detection-yield-performance-and-58837https://curecurrent.com/trials/abemaciclib-with-or-without-atezolizumab-in-metastatic-castration-resistant-prostate-cancer-58838https://curecurrent.com/trials/robot-assisted-vs-laparoscopic-radical-prostatectomy-for-prostate-cancer-treatment-58839https://curecurrent.com/trials/capture-of-prostatic-trans-rectal-ultrasound-scans-for-research-58840https://curecurrent.com/trials/gadoxetate-enhanced-imaging-study-to-detect-prostate-cancer-58841https://curecurrent.com/trials/androgen-deprivation-therapy-or-androgen-deprivation-therapy-plus-definitive-treatment-radiation-or-surgery-58842https://curecurrent.com/trials/daproca-pelvic-lymph-node-irradiation-to-prostate-for-high-risk-prostate-cancer-phase-i-ii-study-58843https://curecurrent.com/trials/ketoconazole-and-dexamethasone-in-prostate-cancer-58844https://curecurrent.com/trials/prosthetics-registry-and-outcomes-in-urology-at-duke-58845https://curecurrent.com/trials/circulating-tumor-cells-in-high-risk-prostate-cancer-treated-with-high-dose-radiotherapy-and-hormone-therapy-58846https://curecurrent.com/trials/docetaxel-or-abiraterone-acetate-with-adt-in-treating-patients-with-metastatic-hormone-sensitive-prostate-cancer-58847https://curecurrent.com/trials/68ga-thp-psma-pet-ct-imaging-in-high-risk-primary-prostate-cancer-or-biochemical-recurrence-of-prostate-cancer-58848https://curecurrent.com/trials/rv001v-a-rhoc-anticancer-vaccine-against-metastasis-from-solid-tumours-58849https://curecurrent.com/trials/salvage-hifu-for-local-recurrence-in-the-prostatic-bed-after-prostatectomy-and-external-beam-radiation-therapy-prelimina-58850https://curecurrent.com/trials/detecting-recurrent-prostate-cancer-with-11c-choline-positron-emission-tomography-58851https://curecurrent.com/trials/prostate-boost-irradiation-with-stereotactic-body-rt-sbrt-58852https://curecurrent.com/trials/early-changes-in-multiparametric-mri-in-prostate-cancer-58853https://curecurrent.com/trials/flame-investigate-the-benefit-of-a-focal-lesion-ablative-microboost-in-prostate-cancer-58854https://curecurrent.com/trials/vaccine-treatment-for-hormone-refractory-prostate-cancer-58855https://curecurrent.com/trials/irreversible-electroporation-ire-for-unresectable-prostatic-neoplasms-58856https://curecurrent.com/trials/prospective-evaluation-of-68-ga-prostate-specific-membrane-antigen-psma-positron-emission-tomograph-pet-and-early-prosta-58857https://curecurrent.com/trials/influence-of-psychosocial-distress-and-lifetime-trauma-exposure-on-traumatic-stress-among-oncology-patients-on-clinical-58858https://curecurrent.com/trials/single-arm-trial-of-preoperative-stereotactic-body-radiation-therapy-sbrt-for-t3a-or-gleason-grade-group-4-prostate-canc-58859https://curecurrent.com/trials/high-dose-stereotactic-radiation-for-prostate-cancer-58860https://curecurrent.com/trials/a-local-retrospective-observational-study-to-evaluate-the-treatment-patterns-of-mcrpc-patients-in-belgium-treated-with-r-58861https://curecurrent.com/trials/survey-of-prostate-cancer-in-accra-ghana-58862https://curecurrent.com/trials/hypofractionated-radiation-therapy-in-prostate-cancer-58863https://curecurrent.com/trials/one-shot-trial-ultra-hypofractionated-single-dose-sbrt-for-prostate-cancer-58864https://curecurrent.com/trials/a-safety-and-efficacy-study-of-shr3680-in-metastatic-castration-resistant-prostate-cancer-patients-58865https://curecurrent.com/trials/zoledronate-in-preventing-skeletal-bone-related-events-in-men-who-are-receiving-androgen-deprivation-therapy-for-prostat-58866https://curecurrent.com/trials/trial-of-methoxyflurane-with-periprostatic-local-anaesthesia-to-reduce-the-discomfort-of-trus-b-58867https://curecurrent.com/trials/evaluation-of-18f-dcfpyl-psma-versus-18f-naf-pet-imaging-for-detection-of-metastatic-prostate-cancer-58868https://curecurrent.com/trials/a-phase-ii-study-of-degarelix-in-the-management-of-non-metastatic-hormone-refractory-prostate-cancer-58869https://curecurrent.com/trials/comparison-of-psma-based-18f-dcfpyl-pet-ct-to-conventional-imaging-in-the-evaluation-of-patients-with-castration-resista-58870https://curecurrent.com/trials/study-of-18f-dcfpyl-a-second-generation-low-molecular-weight-psma-based-pet-radiotracer-in-patients-with-prostate-cancer-58871https://curecurrent.com/trials/study-of-the-clinical-utility-of-psma-imaging-in-the-evaluation-of-men-with-prostate-cancer-58872https://curecurrent.com/trials/a-positron-emission-tomography-computed-tomography-pet-ct-bone-imaging-study-in-patients-receiving-enzalutamide-for-cast-58873https://curecurrent.com/trials/feasibility-study-testing-a-sleep-intervention-in-prostate-cancer-patients-with-insomnia-58874https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetic-behavior-of-leuprolide-mesylate-lmis-25-mg-in-subjects-with-prostate-cancer-58875https://curecurrent.com/trials/pd-l1-expressing-regulatory-t-cells-in-localized-prostate-cancer-patients-undergoing-iodine-125-permanent-brachytherapy-58876https://curecurrent.com/trials/randomized-trial-of-adjuvant-hormonal-therapy-in-surgically-treated-prostate-cancer-patients-at-high-risk-for-recurrence-58877https://curecurrent.com/trials/north-carolina-prostate-cancer-comparative-effectiveness-survivorship-study-nc-process-58878https://curecurrent.com/trials/a-safety-study-of-jnj-56021927-in-participants-with-metastatic-castration-resistant-prostate-cancer-58879https://curecurrent.com/trials/mr-guided-focal-laser-ablation-of-the-prostate-58880https://curecurrent.com/trials/recombinant-human-arginase-1-rharg1-in-patients-with-advanced-arginine-auxotrophic-solid-tumors-58881https://curecurrent.com/trials/exercise-in-men-receiving-radiation-therapy-for-prostate-cancer-58882https://curecurrent.com/trials/3d-conformal-radiation-vs-helical-tomotherapy-in-prostate-cancer-58883https://curecurrent.com/trials/treatment-of-prostate-cancer-with-firmagon-58884https://curecurrent.com/trials/18f-fluorocholine-and-18f-fluoride-pet-in-prostate-cancer-58885https://curecurrent.com/trials/effect-of-adt-in-chinese-male-with-prostate-cancer-58886https://curecurrent.com/trials/goals-of-sexual-function-in-prostate-cancer-survivors-and-their-partners-after-cancer-treatment-58887https://curecurrent.com/trials/a-study-of-docetaxel-arn-509-in-castration-resistant-prostate-cancer-58888https://curecurrent.com/trials/the-effect-of-information-support-program-on-self-efficacy-of-prostate-cancer-patients-during-hormonal-therapy-58889https://curecurrent.com/trials/nosocomial-infections-during-total-prostatic-cystectomies-tpc-with-replacement-enterocystoplasty-prophylactic-role-of-ur-58890https://curecurrent.com/trials/deep-versus-moderate-neuromuscular-blockade-during-laparoscopic-surgery-58891https://curecurrent.com/trials/zd-1839-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-58892https://curecurrent.com/trials/combination-chemotherapy-in-treating-pain-in-hormone-refractory-metastatic-prostate-cancer-58893https://curecurrent.com/trials/phase-ii-study-of-sipuleucel-t-and-indoximod-for-patients-with-refractory-metastatic-prostate-cancer-58894https://curecurrent.com/trials/hormone-therapy-with-or-without-surgery-or-radiation-therapy-in-treating-patients-with-prostate-cancer-58895https://curecurrent.com/trials/vitamin-e-selenium-and-soy-protein-in-preventing-cancer-in-patients-with-high-grade-prostate-neoplasia-58896https://curecurrent.com/trials/navigant-study-treatment-patterns-in-mcrpc-metastatic-castrate-resistant-prostate-cancer-58897https://curecurrent.com/trials/dendreon-lymph-node-biopsy-in-metastatic-castrate-resistant-prostate-cancer-58898https://curecurrent.com/trials/trial-of-erapa-in-prostate-cancer-patients-58899https://curecurrent.com/trials/observational-longitudinal-study-of-pain-in-men-with-metastatic-castrate-resistant-prostate-cancer-58900https://curecurrent.com/trials/analyses-of-human-samples-collected-in-clinical-trials-58901https://curecurrent.com/trials/combining-advances-in-imaging-with-biomarkers-for-improved-diagnosis-of-aggressive-prostate-cancer-58902https://curecurrent.com/trials/the-prostate-liquid-study-plis-58903https://curecurrent.com/trials/magnetic-resonance-imaging-in-measuring-the-effect-of-cabozantinib-in-patients-with-castrate-resistant-prostate-cancer-58904https://curecurrent.com/trials/combined-prostate-specific-antigen-multi-parametric-mri-and-targeted-prostate-biopsy-for-prostate-cancer-screening-58905https://curecurrent.com/trials/testosterone-cognition-ageing-and-cancer-58906https://curecurrent.com/trials/mr-target-biopsy-vs-trus-biopsy-in-men-with-suspicious-prostate-cancer-58907https://curecurrent.com/trials/radical-retropubic-prostatectomy-versus-conventional-external-beam-radiotherapy-for-clinically-localized-prostate-cancer-58908https://curecurrent.com/trials/rct-evaluation-of-retzius-sparing-robotic-prostatectomy-58909https://curecurrent.com/trials/mri-guided-prostate-cancer-focal-laser-ablation-58910https://curecurrent.com/trials/screening-for-prostate-cancer-among-those-prostate-specific-antigen-value-between-2-5-and-4-0-ng-ml-58911https://curecurrent.com/trials/neoadjuvant-apalutamide-arn509-and-radical-prostatectomy-in-treatment-of-intermediate-to-high-risk-prostate-cancer-58912https://curecurrent.com/trials/infectious-outcomes-of-povidone-iodine-rectal-cleansing-plus-formalin-disinfection-of-needle-during-prostate-biopsy-58913https://curecurrent.com/trials/zoledronic-acid-with-intermittent-hormonal-therapy-in-patients-with-prostate-cancer-58914https://curecurrent.com/trials/prospective-multicenter-observational-study-on-elective-pelvic-nodes-irradiation-58915https://curecurrent.com/trials/trial-of-abiraterone-acetate-plus-lhrh-therapy-versus-abiraterone-acetate-sparing-lhrh-therapy-in-patients-with-progress-58916https://curecurrent.com/trials/improving-cancer-foci-detection-in-prostate-cancer-using-multiparametric-mri-mrs-58917https://curecurrent.com/trials/effects-of-high-intensity-training-compared-to-resistance-training-in-cancer-patients-undergoing-radiotherapy-58918https://curecurrent.com/trials/a-safety-and-efficacy-study-of-oral-mdv3100-in-chemotherapy-naive-patients-with-progressive-metastatic-prostate-cancer-58919https://curecurrent.com/trials/safety-tolerability-and-pk-of-gt0918-proxalutamide-in-subjects-with-metastatic-castrate-prostate-cancer-58920https://curecurrent.com/trials/effect-of-neuromuscular-block-and-arterial-pco2-on-surgical-rating-scale-srs-following-reversal-with-sugammadex-58921https://curecurrent.com/trials/genetic-analysis-of-hereditary-prostate-cancer-58922https://curecurrent.com/trials/prostatic-urethral-lift-pul-pre-post-radiation-treatment-for-prostate-cancer-58923https://curecurrent.com/trials/the-role-of-highly-selective-androgen-receptor-ar-targeted-therapy-in-men-with-biochemically-relapsed-hormone-sensitive-58924https://curecurrent.com/trials/a-phase-i-study-of-pcur-101-in-combination-with-androgen-suppression-therapy-in-the-treatment-of-patients-with-metastati-58925https://curecurrent.com/trials/pretreatment-staging-of-high-risk-prostate-cancer-with-18f-fluciclovine-pet-mri-58926https://curecurrent.com/trials/177lu-psma-i-t-prior-to-radical-prostatectomy-for-locally-advanced-disease-58927https://curecurrent.com/trials/problem-solving-therapy-for-prostate-cancer-spousal-caregivers-58928https://curecurrent.com/trials/pilot-study-of-plx3397-in-patients-with-advanced-castration-resistant-prostate-cancer-crpc-58929https://curecurrent.com/trials/prostate-cancer-risk-in-firefighters-58930https://curecurrent.com/trials/comparison-of-prostate-fusion-biopsies-with-software-and-cognitive-58931https://curecurrent.com/trials/fasting-mimicking-diet-in-prostate-cancer-and-metabolic-syndrome-58932https://curecurrent.com/trials/apalutamide-plus-intermittent-hormone-therapy-versus-intermittent-hormone-therapy-alone-in-prostate-cancer-58933https://curecurrent.com/trials/imaging-biomarkers-to-validate-response-in-enzalutamide-treated-mcrpc-58934https://curecurrent.com/trials/educational-program-plus-physiotherapy-after-prostatectomy-58935https://curecurrent.com/trials/impact-of-magnetic-resonance-and-biomarkers-for-screening-for-prostate-cancer-cost-effectiveness-analysis-58936https://curecurrent.com/trials/antibiotic-prophylaxis-in-transurethral-prostate-resection-turp-and-transurethral-bladder-tumour-resection-turb-58937https://curecurrent.com/trials/prostate-cancer-intervention-versus-observation-trial-pivot-58938https://curecurrent.com/trials/fertility-after-prostate-brachytherapy-58939https://curecurrent.com/trials/correlative-analysis-of-the-genomics-of-vitamin-d-and-omega-3-fatty-acid-intake-in-prostate-cancer-58940https://curecurrent.com/trials/cohorts-of-docetaxel-or-cabazitaxel-in-combination-with-the-potent-cyp3a4-inhibitor-clarithromycin-58941https://curecurrent.com/trials/phase-i-iia-study-of-pet-imaging-with-89zr-df-iab2m-in-metastatic-prostate-cancer-58942https://curecurrent.com/trials/comparison-of-pet-with-89zr-df-iab2m-and-111in-capromab-pendetide-in-the-detection-of-prostate-cancer-pre-prostatectomy-58943https://curecurrent.com/trials/national-danish-protocol-surgery-sbrt-for-m1-prostate-cancer-patients-58944https://curecurrent.com/trials/upregulation-of-psma-receptors-after-androgen-deprivation-therapy-on-psma-pet-ct-imaging-in-prostate-cancer-58945https://curecurrent.com/trials/safety-study-of-mri-guided-transurethral-ultrasound-ablation-of-prostate-tissue-to-treat-localized-prostate-cancer-58946https://curecurrent.com/trials/use-of-pedometer-following-radical-prostatectomy-58947https://curecurrent.com/trials/study-of-the-effect-of-chemotherapy-with-cabazitaxel-on-prostate-cancer-58948https://curecurrent.com/trials/vaccination-in-prostate-cancer-vance-58949https://curecurrent.com/trials/3t-perfluorocarbon-filled-endorectal-magnetic-resonance-spectroscopic-imaging-of-prostate-58950https://curecurrent.com/trials/comparing-hypofractionated-radiotherapy-boost-to-conventionally-fractionated-58951https://curecurrent.com/trials/patient-centered-communication-of-life-expectancy-estimates-in-genitourinary-malignancies-58952https://curecurrent.com/trials/data-visualization-of-kidney-and-prostate-tumors-using-routine-pre-operative-imaging-3d-printed-and-3d-virtual-reality-m-58953https://curecurrent.com/trials/prospective-evaluation-of-hypofractionated-stereotactic-rt-using-cyberknife-for-patients-with-prostate-cancer-58954https://curecurrent.com/trials/evaluation-of-a-blood-biomarker-to-try-and-distinguish-between-the-presence-or-absence-of-aggressive-prostate-cancer-58955https://curecurrent.com/trials/itraconazole-in-treating-patients-with-biochemically-relapsed-prostate-cancer-58956https://curecurrent.com/trials/pomegranate-extract-pill-in-preventing-tumor-growth-in-patients-with-localized-prostate-cancer-undergoing-active-surveil-58957https://curecurrent.com/trials/effect-of-modified-citrus-pectin-on-psa-kinetics-in-biochemical-relapsed-pc-with-serial-increases-in-psa-58958https://curecurrent.com/trials/minocycline-attenuate-postoperative-cognitive-dysfunction-and-delirium-58959https://curecurrent.com/trials/prosabi-prospective-multi-centre-study-of-prognostic-factors-in-mcrpc-patients-treated-with-abiraterone-acetate-58960https://curecurrent.com/trials/us-ct-fusion-for-post-implant-dosimetry-58961https://curecurrent.com/trials/f18-psma-1007-pet-for-early-biochemical-recurrence-of-prostate-cancer-58962https://curecurrent.com/trials/prostac-prospective-multi-centre-study-of-prognostic-factors-in-mcrpc-patients-treated-with-docetaxel-or-cabazitaxel-58963https://curecurrent.com/trials/robotic-surgery-after-focal-ablation-therapy-58964https://curecurrent.com/trials/prosenza-prospective-multi-centre-study-of-prognostic-factors-in-mcrpc-patients-treated-with-enzalutamide-58965https://curecurrent.com/trials/relationship-of-mitochondrial-enzymes-with-cancer-related-fatigue-58966https://curecurrent.com/trials/feasibility-and-toxicity-of-degarelix-for-prostate-downsizing-prior-to-permanent-seed-prostate-brachytherapy-58967https://curecurrent.com/trials/proradium-prospective-multi-centre-study-of-prognostic-factors-in-mcrpc-patients-treated-with-radium-223-58968https://curecurrent.com/trials/carboplatin-in-castration-resistant-prostate-cancer-58969https://curecurrent.com/trials/the-role-of-follicle-stimulating-hormone-in-advanced-prostate-cancer-58970https://curecurrent.com/trials/stereotactic-pelvic-brachytherapy-with-hdr-boost-for-dose-escalation-in-high-tier-intermediate-and-high-risk-prostate-ca-58971https://curecurrent.com/trials/multiparametric-mri-for-prostate-cancer-localization-and-characterization-using-hyperpolarized-pyruvate-13c-injection-58972https://curecurrent.com/trials/true-nth-sexual-recovery-intervention-for-prostate-cancer-survivors-and-their-partners-58973https://curecurrent.com/trials/improving-prostate-cancer-detection-using-mri-targeted-trus-guided-biopsy-58974https://curecurrent.com/trials/study-of-abiraterone-acetate-plus-prednisone-in-patients-with-chemo-naive-metastatic-castration-resistant-prostate-cance-58975https://curecurrent.com/trials/a-phase-1-1b-study-of-medi3726-in-adults-subjects-with-metastatic-castration-resistant-prostate-cancer-58976https://curecurrent.com/trials/analysis-of-cell-free-dna-cfdna-in-men-with-elevated-psa-levels-58977https://curecurrent.com/trials/comprehensive-lifestyle-improvement-program-for-men-with-prostate-cancer-58978https://curecurrent.com/trials/quality-of-life-study-for-prostate-cancer-patients-58979https://curecurrent.com/trials/walking-football-as-a-supportive-medicine-for-patients-with-prostate-cancer-58980https://curecurrent.com/trials/anorectal-application-of-5-lidocaine-cream-reduces-pain-prior-to-periprostatic-nerve-block-during-transrectal-ultrasound-58981https://curecurrent.com/trials/study-of-abiraterone-acetate-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-chemo-naive-who-58982https://curecurrent.com/trials/clinical-trial-of-ac225-psma-radioligand-therapy-of-metastatic-castration-resistant-prostate-cancer-58983https://curecurrent.com/trials/biomarkers-of-androgen-response-and-resistance-in-evolution-during-a-rising-psa-58984https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-ii-or-stage-iii-prostate-cancer-58985https://curecurrent.com/trials/study-of-natural-killer-cells-in-patients-with-metastatic-prostate-cancer-relationship-with-survival-and-response-time-t-58986https://curecurrent.com/trials/neoadjuvant-chemo-hormonal-therapy-combined-with-radical-prostatectomy-for-locally-advanced-prostate-cancer-58987https://curecurrent.com/trials/study-of-quality-of-life-for-prostate-proton-therapy-58988https://curecurrent.com/trials/facbc-prostate-therapy-response-58989https://curecurrent.com/trials/prostate-sabr-with-intra-prostatic-sabr-boost-58990https://curecurrent.com/trials/leuprolide-acetate-or-goserelin-acetate-compared-with-observation-in-treating-patients-with-high-risk-prostate-cancer-wh-58991https://curecurrent.com/trials/impact-of-catheter-size-on-peri-operative-pain-after-robotic-assisted-laparoscopic-prostatectomy-58992https://curecurrent.com/trials/prostate-cancer-survivors-and-exercise-and-behavioral-counseling-58993https://curecurrent.com/trials/a-study-to-describe-patterns-of-care-and-outcomes-of-men-who-are-at-high-risk-after-experiencing-biochemical-failure-fol-58994https://curecurrent.com/trials/safety-and-pharmacokinetics-of-odm-204-in-patients-with-metastatic-castration-resistant-prostate-cancer-58995https://curecurrent.com/trials/prostate-cancer-exercise-study-pro-test-58996https://curecurrent.com/trials/lycopene-in-treating-patients-undergoing-radical-prostatectomy-for-prostate-cancer-58997https://curecurrent.com/trials/the-composite-steep-pulse-treatment-apparatus-used-in-prostate-cancer-ablation-therapy-58998https://curecurrent.com/trials/expanded-access-to-diagnostic-imaging-for-staging-of-recurrent-prostate-cancer-58999https://curecurrent.com/trials/focal-laser-ablation-for-the-treatment-of-focal-low-intermediate-risk-prostate-cancer-59000